MAIZE GLUTATHIONE-S-TRANSFERASE ENZYMES

Abstract: This invention relates to isolated nucleic acid fragments encoding all or a substantial portion of maize glutathione-S-transferase (GST) enzymes involved in the detoxification of xenobiotic compounds in plants and seeds. The invention also relates to the construction of chimeric genes encoding all or a substantial portion of maize GST enzymes, host cells transformed with those genes and methods of the recombinant production of maize GST enzymes. Methods of constructing transgenic plants having altered levels of GST enzymes and screens for identifying maize GST enzyme substrates and maize GST enzyme inhibitor, are also provided.

Description: TITLE MAIZE GLUTATHIONE-S-TRANSFERASE ENZYMES FIELD OF THE INVENTION This invention is in the field of plant molecular biology. More specifically, this invention pertains to nucleic acid fragments encoding maize glutathione-S-transferase (GST) enzymes involved in the detoxification of xenobiotic compounds in plants and seeds. BACKGROUND OF THE INVENTION Glutathione-S-transferases (GST) are a family of enzymes which catalyze the conjugation of glutathione, homoglutathione (hGSH) and other glutathione- like analogs via a sulfhydryl group, to a large range of hydrophobic, electrophilic compounds. The conjugation can result in detoxification of these compounds. GST enzymes have been identified in a range of plants including maize (Wosnick et al, Gene (Amst) 16 (1) (1989) 153-160; Rossini et al., Plant Physiology (Rockville) 112 (4) (1996) 1595-1600; Holt et al., Planta (Heidelberg) 196 (2) (1995) 295-302), wheat (Edwards et al., Pestic. Biochem. Physiol. (1996) 54(2), 96-104), sorghum (Hatzios et al., J. Environ. Sci. Health, Part B (1996), B31(3), 545-553), arabidopsis (Van Der Kop et al, Plant Molecular Biology 30 (4) (1996), sugarcane (Singhal et al., Phytochemistry (OXF) 30 (5) (1991) 1409-1414), soybean (Flury et al, Physiologia Plantarum 94 (1995) 594-604) and peas (Edwards R., Physiologia Plantarum 98 (3) (1996) 594-604). GST's can comprise a significant portion of total plant protein, for example attaining from 1 to 2% of the total soluble protein in etiolated maize seedlings (Timmermann, Physiol. Plant. (1989) 77(3), 465-71). Glutathione S-transferases (GSTs; EC 2.5.1.18) catalyze the nucleophilic attack of the thiol group of GSH to various electrophilic substrates. Their functions and regulation in plants has been recently reviewed (Marrs et al., Annu Rev Plant Physiol Plant Mol Biol 47:127-58 (1996); Droog, F. J Plant Growth Regul 16:95-107, (1997)). They are present at every stage of plant development from early embryogenesis to senescence and in every tissue class examined. The agents that have been shown to cause an increase in GST levels have the potential to cause oxidative destruction in plants, suggesting a role for GSTs in the protection from oxidative damage. In addition to their role in the protection from oxidative damage, GSTs have the ability to nonenzymatically bind certain small molecules, such as auxin (Zettl et al. , PNAS 91 :689-693, (1994)) and perhaps regulate their bioavailability. Furthermore the addition of GSH to a molecule serves as an "address" to send that molecule to the plant vacuole (Marrs et al., Nature 375:397-400, (1995)). GSTs have also been implicated in the detoxification of certain herbicides. Maize GSTs have been well characterized in relation to herbicide metabolism. Three genes from maize have been cloned: GST 29 (Shah et al. , Plant Mol Biol 6, 203-211(1986)), GST 27 (Jepson et al., Plant Mol Biol 26:1855-1866, (1994)), GST 26 (Moore et al., Nucleic Acids Res 14:7227-7235 (1986)). These gene products form four GST isoforms: GST I (a homodimer of GST 29), GST II (a heterodimer of GST 29 and GST 27), GST III (a homodimer of GST 26), and GST IV (a homodimer of GST 27). GST 27 is highly inducible by safener compounds (Jepson (1994) supra; Holt et al., Planta 196:295-302, (1995)) and overexpression of GST 27 in tobacco confers alachlor resistance to transgenic tobacco (Jepson, personal communication). Additionally, Bridges et al. (U.S. 5589614) disclose the sequence of a maize derived GST isoform II promoter useful for the expression of foreign genes in maize and wheat. In soybean, herbicide compounds conjugated to hGSH have been detected and correlated with herbicide selectivity (Frear et al. , Physiol 20: 299-310 (1983); Brown et al. , Rest Biochem Physiol 29: 112-120, (1987)). This implies that hGSH conjugation is an important determinant in soybean herbicide selectivity although this hypothesis has not been characterized on a molecular level. Some efforts have been made to alter plant phenotypes by the expression of either plant or mammalian foreign GST genes or their promoters in mature plant tissue. For example, Helmer et al. (U.S. 5073677) teach the expression of a rat GST gene in tobacco under the control of a strong plant promoter. Similarly, Jepson et al. (WO 97/11189) disclose a chemically inducible maize GST promoter useful for the expression of foreign proteins in plants; Chilton et al. (EP 256223) discuss the construction of herbicide tolerant plants expressing a foreign plant GST gene; and Bieseler et al. (WO 96/23072) teach DNA encoding GSTIIIc, its recombinant production and transgenic plants containing the DNA having a herbicide-tolerant phenotype. Manipulation of nucleic acid fragments encoding soybean GST to use in screening in assays, the creation of herbicide-tolerant transgenic plants, and altered production of GST enzymes depend on the heretofore unrealized isolation of nucleic acid fragments that encode all or a substantial portion of a soybean GST enzyme. SUMMARY OF THE INVENTION The present invention provides nucleic acid fragments isolated from maize encoding all or a substantial portion of a GST enzyme. The isolated nucleic acid fragment is selected from the group consisting of (a) an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO: 10, SEQ ID NO:12, SEQ ID NO.14, SEQ ID NO:16, SEQ ID NO: 18, SEQ ID NO:20, SEQ ID NO:22, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:38, SEQ ID NO:40, SEQ ID NO:42, SEQ ID NO:44, SEQ ID NO:46, SEQ ID NO:48, SEQ ID NO:50, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72 and SEQ ID NO: 74; (b) an isolated nucleic acid fragment that is substantially similar to an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO:20, SEQ ID NO:22, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:38, SEQ ID NO:40, SEQ ID NO:42, SEQ ID NO:44, SEQ ID NO:46, SEQ ID NO:48, SEQ ID NO:50, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72 and SEQ ID NO:74.; and (c) an isolated nucleic acid fragment that is complementary to (a) or (b). The nucleic acid fragments and corresponding polypeptides are contained in the accompanying Sequence Listing and described in the Brief Description of the Invention. In another embodiment, the instant invention relates to chimeric genes encoding maize GST enzymes or to chimeric genes that comprise nucleic acid fragments as described above, the chimeric genes operably linked to suitable regulatory sequences, wherein expression of the chimeric genes results in altered levels of the encoded enzymes in transformed host cells. The present invention further provides a transformed host cell comprising the above described chimeric gene. The transformed host cells can be of eukaryotic or prokaryotic origin. The invention also includes transformed plants that arise from transformed host cells of higher plants, and from seeds derived from such transformed plants, and subsequent progeny. Additionally, the invention provides methods of altering the level of expression of a maize GST enzyme in a host cell comprising the steps of; (i) transforming a host cell with the above described chimeric gene and; (ii) growing the transformed host cell produced in step (i) under conditions that are suitable for expression of the chimeric gene wherein expression of the chimeric gene results in production of altered levels of a plant GST enzyme in the transformed host cell relative to expression levels of an untransformed host cell. In an alternate embodiment, the present invention provides methods of obtaining a nucleic acid fragment encoding all or substantially all of the amino acid sequence encoding a maize GST enzyme comprising either hybridization or primer-directed amplification methods known in the art and using the above described nucleic acid fragment. A primer-amplification-based method uses SEQ ID NOS..1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71 or 73. The product of these methods is also part of the invention. Another embodiment of the invention includes a method for identifying a compound that inhibits the activity of a maize GST enzyme encoded by the nucleic acid fragment and substantially similar and complementary nucleic acid fragments of SEQ ID NOS.:l, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71 and 73. The method has the steps: (a) transforming a host cell with the above described chimeric gene; (b) growing the transformed host cell under conditions that are suitable for expression of the chimeric gene wherein expression of the chimeric gene results in production of the GST enzyme; (c) optionally purifying the GST enzyme expressed by the transformed host cell; (d) contacting the GST enzyme with a chemical compound of interest; and (e) identifying the chemical compound of interest that reduces the activity of the maize GST enzyme relative to the activity of the maize GST enzyme in the absence of the chemical compound of interest. This method may further include conducting step (d) in the presence of at least one electrophilic substrate and at least one thiol donor. The isolated nucleic acid fragments of this method are chosen from the group represented by SEQ ID NOS..1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71 and 73 and the maize GST enzyme is selected from the group consisting of SEQ ID NOS.:2, 4, 6, 8,10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, and 74. The invention further provides a method for identifying a chemical compound that inhibits the activity of the maize GST enzyme as described herein, wherein the identification is based on a comparison of the phenotype of a plant transformed with the above described chimeric gene contacted with the inhibitor candidate with the phenotype of a transformed plant that is not contacted with the inhibitor candidate. The isolated nucleic acid fragment of this method is selected from the group consisting of SEQ ID NOS.:l, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71 and 73 and the maize GST enzyme is selected from the group consisting of SEQ ID NOS..2, 4, 6, 8,10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, and 74. In another embodiment, the invention provides a method for identifying a substrate for the maize GST enzyme. The method comprises the steps of: (a) transforming a host cell with a chimeric gene comprising the nucleic acid fragment as described herein, the chimeric gene encoding a maize GST enzyme operably linked to at least one suitable regulatory sequence; (b) growing the transformed host cell of step (a) under conditions that are suitable for expression of the chimeric gene resulting in production of the GST enzyme; (c) optionally purifying the GST enzyme expressed by the transformed host cell; (d) contacting the GST enzyme with a substrate candidate; and (e) comparing the activity of maize GST enzyme with the activity of maize GST enzyme that has been contacted with the substrate candidate and selecting substrate candidates that increase the activity of the maize GST enzyme relative to the activity of maize GST enzyme in the absence of the substrate candidate. More preferably, step (d) of this method is carried out in the presence of at least one thiol donor. The isolated nucleic acid fragment of this method is selected from the group consisting of SEQ ID NOS..1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71 and 73 and the maize GST enzyme is selected from the group consisting of SEQ ID NOS.:2, 4, 6, 8,10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, and 74. Alternatively, methods are provided for identifying a maize GST substrate candidate wherein the identification of the substrate candidate is based on a comparison of the phenotype of a host cell transformed with a chimeric gene expressing a maize GST enzyme and contacted with a substrate candidate with the phenotype of a similarly transformed host cell grown without contact with a substrate candidate. The isolated nucleic acid fragment of this method is selected from the group consisting of SEQ ID NOS.-.l, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71 and 73 and the maize GST enzyme is selected from the group consisting of SEQ ID NOS..2, 4, 6, 8,10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, and 74. BRIEF DESCRIPTION OF SEQUENCE DESCRIPTIONS AND BIOLOGICAL DEPOSITS The invention can be more fully understood from the following detailed description and the accompanying sequence descriptions and biological deposits which form a part of this application. The following sequence descriptions and sequences listings attached hereto comply with the rules governing nucleotide and/or amino acid sequence disclosures in patent applications as set forth in 37 C.F.R. §1.821-1.825. The Sequence Descriptions contain the one letter code for nucleotide sequence characters and the three letter codes for amino acids as defined in conformity with the IUPAC-IYUB standards described in Nucleic Acids Research 75:3021-3030 (1985) and in the Biochemical Journal 219 (No. 2j:345-373 (1984) which are herein incorporated by reference. SEQ ID NO:l is the nucleotide sequence comprising the cDNA insert in clone bmsl .pk0023.g8 encoding a maize GST. SEQ ID NO:2 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone bmsl.pk0023.g8. SEQ ID NO: 3 is the nucleotide sequence comprising the cDNA insert in clone cs.pk0010.c5 encoding a maize GST. SEQ ID NO:4 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone cs.pk0010.c5. SEQ ID NO: 5 is the nucleotide sequence comprising the cDNA insert in clone cebl.pk0017.a5 encoding a maize GST. SEQ ID NO:6 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone cebl .pkOOl 7.a5. SEQ ID NO: 7 is the nucleotide sequence comprising the cDNA insert in clone cc71se-a.pk0001.g2 encoding a maize class III GST. SEQ ID NO: 8 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone cc71se-a.pk0001.g2. SEQ ID NO:9 is the nucleotide sequence comprising the cDNA insert in clone cc71se-b.pk0014.b8 encoding a maize class III GST. SEQ ID NO: 10 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone cc71se-b.pk0014.b8. SEQ ID NO:l 1 is the nucleotide sequence comprising the cDNA insert in clone ceb5.pk0051.f8 encoding a maize class III GST. SEQ ID NO: 12 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone ceb5.pk0051.f8. SEQ ID NO: 13 is the nucleotide sequence comprising the cDNA insert in clone crln.pk0003.bl encoding a maize class III GST. SEQ ID NO: 14 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone crln.pk0003.bl. SEQ ID NO: 15 is the nucleotide sequence comprising the cDNA insert in clone crln.pk0014.g8 encoding a maize class III GST. SEQ ID NO: 16 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone crln.pk0014.g8. SEQ ID NO: 17 is the nucleotide sequence comprising the cDNA insert in clone m.l5.5.d06.sk20 encoding a maize class II GST. SEQ ID NO: 18 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone m.l5.5.d06.sk20. SEQ ID NO: 19 is the nucleotide sequence comprising the cDNA insert in clone crln.pk0040.el2 encoding a maize class II GST. SEQ ID NO:20 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone crln.pk0040.el2. SEQ ID NO:21 is the nucleotide sequence comprising the cDNA insert in clone ceb5.pk0049.al 1 encoding a maize class III GST. SEQ ID NO:22 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone ceb5.pk0049.al 1. SEQ ID NO:23 is the nucleotide sequence comprising the cDNA insert in clone csl.pk0059.e2 encoding a maize class III GST. SEQ ID NO:24 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone csl.pk0059.e2. SEQ ID NO:25 is the nucleotide sequence comprising the cDNA insert in clone cbn2.pk0032.dl0 encoding a maize class I GST. SEQ ID NO:26 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone cbn2.pk0032.dl0 SEQ ID NO:27 is the nucleotide sequence comprising the cDNA insert in clone crln.pk0164.g7 encoding a maize class I GST. SEQ ID NO:28 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone crln.pk0164.g7 SEQ ID NO:29 is the nucleotide sequence comprising the cDNA insert in clone cdt2c.pk003.115 encoding a maize class I GST. SEQ ID NO:30 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone cdt2c.pk003.115 SEQ ID NO:31 is the nucleotide sequence comprising the cDNA insert in clone csclc.pk001.h7 encoding a maize class I GST. SEQ ID NO:32 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone csclc.pk001.h7 SEQ ID NO:31 is the nucleotide sequence comprising the cDNA insert in clone csclc.pk001.h7 encoding a maize class I GST. SEQ ID NO:32 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone csclc.pk001.h7 SEQ ID NO:33 is the nucleotide sequence comprising the cDNA insert in clone p0110.cgsnt78r encoding a maize class I GST. SEQ ID NO:34 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone pOl 10.cgsnt78r. SEQ ID NO:35 is the nucleotide sequence comprising the cDNA insert in clone p0121.cfrmz42r encoding a maize class I GST. SEQ ID NO:36 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone p0121.cfrmz42r. SEQ ID NO:37 is the nucleotide sequence comprising the cDNA insert in clone csiln.pk0034.all encoding a maize class III GST. SEQ ID NO:38 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone csiln.pk0034.all. SEQ ID NO:39 is the nucleotide sequence comprising the cDNA insert in clone cepe7.pk0028.g3 encoding a maize class III GST. SEQ ID NO:40 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone cepe7.pk0028.g3. SEQ ID NO:41 is the nucleotide sequence comprising the cDNA insert in clone crln.pk0167.d7 encoding a maize class III GST. SEQ ID NO:42 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone crln.pk0167.d7. SEQ ID NO:43 is the nucleotide sequence comprising the cDNA insert in clone ccol.pk0027.e4 encoding a maize class III GST. SEQ ID NO:44 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone ccol.pk0027.e4. SEQ ID NO:45 is the nucleotide sequence comprising the cDNA insert in clone cpjlc.pk001.d21 encoding a maize class III GST. SEQ ID NO:46 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone cpjlc.pk001.d21. SEQ ID NO:47 is the nucleotide sequence comprising the cDNA insert in clone cselc.pk001.b8 encoding a maize class III GST. SEQ ID NO:48 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone cselc.pk001.b8. SEQ ID NO:49 is the nucleotide sequence comprising the cDNA insert in clone crls.pk010.fl encoding a maize class III GST. SEQ ID NO: 50 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone crls.pk010.fl. SEQ ID NO: 51 is the nucleotide sequence comprising the cDNA insert in clone cpflc.pk002.al3 encoding a maize class III GST. SEQ ID NO:52 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone cpflc.pk002.al3. SEQ ID NO:53 is the nucleotide sequence comprising the cDNA insert in clone cholc.pk004.cl5 encoding a maize class III GST. SEQ ID NO:54 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone cholc.pk004.cl5. SEQ ID NO:55 is the nucleotide sequence comprising the cDNA insert in clone cpilc.pk002.m4 encoding a maize class III GST. SEQ ID NO:56 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone cpilc.pk002.m4. SEQ ID NO:57 is the nucleotide sequence comprising the cDNA insert in clone chpc8.pk057.fl0 encoding a maize class III GST. SEQ ID NO:58 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone chpc8.pk057.fl0. SEQ ID NO: 59 is the nucleotide sequence comprising the cDNA insert in clone p0014.ctu90r encoding a maize class III GST. SEQ ID NO:60 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone p0014.ctu90r. SEQ ID NO:61 is the nucleotide sequence comprising the cDNA insert in p0006.cbyvs55r encoding a maize class III GST. SEQ ID NO:62 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone p0006.cbyvs55r. SEQ ID NO: 63 is the nucleotide sequence comprising the cDNA insert in p0037.crwaf68r encoding a maize class III GST. SEQ ID NO: 64 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone p0037.crwaf68r. SEQ ID NO: 65 is the nucleotide sequence comprising the cDNA insert in p0032.crcas61r encoding a maize class III GST. SEQ ID NO: 66 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone p0032.crcas61r. SEQ ID NO: 67 is the nucleotide sequence comprising the cDNA insert in p0088.clrim45r encoding a maize class III GST. SEQ ID NO: 68 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone p0088.clrim45r. SEQ ID NO:69 is the nucleotide sequence comprising the cDNA insert in p0126.cnlag50r encoding a maize class III GST. SEQ ID NO: 70 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone p0126.cnlag50r. SEQ ID NO:71 is the nucleotide sequence comprising the cDNA insert in p0095.cwsba73r encoding a maize class III GST. SEQ ID NO: 72 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone p0095.cwsba73r. SEQ ID NO: 73 is the nucleotide sequence comprising the cDNA insert in p0125.czaaj03r encoding a maize class III GST. SEQ ID NO: 74 is the deduced amino acid sequence of the nucleotide sequence comprising the cDNA insert in clone p0125.czaaj03r. The transformed E. coli ceb5.pk0051.f8/pET30(LIC)BL21(DE3) containing the gene ceb5.pk0051.f8 in a pET30(LIC) vector encoding a maize class III GST was deposited on 21 August 1997 with the American Type Culture Collection (ATCC), 10801 University Boulevard, Manassas, VA 20110-2209, U.S.A., under the terms of the Budapest Treaty on the International Recognition of the Deposit of Micro-organisms for the Purpose of Patent Procedure. The deposit is designated as ATCC 98511. DETAILED DESCRIPTION OF THE INVENTION The present invention provides novel GST nucleotide sequences and encoded proteins isolated from maize. GST enzymes are known to function in the process of detoxification of a variety of xenobiotic compounds in plants, most notably, herbicides. Nucleic acid fragments encoding at least a portion of several maize GST enzymes have been isolated and identified by comparison of random plant cDNA sequences to public databases containing nucleotide and protein sequences using the BLAST algorithms well known to those skilled in the art. The sequences of the present invention are useful in the construction of herbicide-tolerant transgenic plants, in the recombinant production of GST enzymes, in the development of screening assays to identify compounds inhibitory to the GST enzymes, and in screening assays to identify chemical substrates of the GSTs. In the context of this disclosure, a number of terms shall be utilized. As use herein "Glutathione S-Transferase" or "GST" refers to any plant derived glutathione S-transferase (GST) enzyme capable of catalyzing the conjugation of glutathione, homoglutathione and other glutathione-like analogs via a sulfhydryl group, to hydrophobic and electrophilic compounds. The term GST includes amino acid sequences longer or shorter than the length of natural GSTs, such as functional hybrid or partial fragments of GSTs, or their analogues. As used herein "GST" is not intended to be delimited on the basis of enzyme activity but may encompass amino acid sequences that possess no measurable enzyme activity but are substantially similar in to those sequences, known in the art to possess the above mentioned glutathione conjugating activity. The term "class" or "GST class" refers to a grouping of the various GST enzymes according to amino acid identity. Currently, four classes have been identified and are referred to as "GST class I" "GST class II", "GST class III" and "GST class IV" . The grouping of plant GSTs into three classes is described by Droog et al. (Plant Physiology 107:1139-1146 (1995)). All available amino acid sequences were aligned using the Wisconsin Genetics Computer Group package (Wisconsin Package Version 9.0, Genetics Computer Group (GCG), Madison, WI), and graphically represented on a phylogenetic tree. Three groups were identified: class one including the archetypical sequences from maize GST I (X06755) and GST III (X04375); class two including the archetypical sequence from Dianthus caryophyllus (M64628); and class three including the archetypical sequence soybean GH2/4 (M20363). Recently, Applicants have established a further subgroup of the plant GSTs known as class IV GSTs with its archetypical sequence being In2-1 (X58573). As used herein, an "isolated nucleic acid fragment" is a polymer of RNA or DNA that is single- or double-stranded, optionally containing synthetic, non- natural or altered nucleotide bases. An isolated nucleic acid fragment in the form of a polymer of DNA may be comprised of one or more segments of cDNA, genomic DNA or synthetic DNA. As used herein, "substantially similar" refers to nucleic acid fragments wherein changes in one or more nucleotide bases results in substitution of one or more amino acids, but do not affect the functional properties of the protein encoded by the DNA sequence. "Substantially similar" also refers to nucleic acid fragments wherein changes in one or more nucleotide bases does not affect the ability of the nucleic acid fragment to mediate alteration of gene expression by antisense or co-suppression technology. "Substantially similar" also refers to modifications of the nucleic acid fragments of the instant invention such as deletion or insertion of one or more nucleotide bases that do not substantially affect the functional properties of the resulting transcript vis-a-vis the ability to mediate alteration of gene expression by antisense or co-suppression technology or alteration of the functional properties of the resulting protein molecule. It is therefore understood that the invention encompasses more than the specific exemplary sequences. For example, it is well known in the art that antisense suppression and co- suppression of gene expression may be accomplished using nucleic acid fragments representing less that the entire coding region of a gene, and by nucleic acid fragments that do not share 100% identity with the gene to be suppressed. Moreover, alterations in a gene which result in the production of a chemically equivalent amino acid at a given site, but do not effect the functional properties of the encoded protein, are well known in the art. Thus, a codon for the amino acid alanine, a hydrophobic amino acid, may be substituted by a codon encoding another less hydrophobic residue (such as glycine) or a more hydrophobic residue (such as valine, leucine, or isoleucine). Similarly, changes which result in substitution of one negatively charged residue for another (such as aspartic acid for glutamic acid) or one positively charged residue for another (such as lysine for arginine) can also be expected to produce a functionally equivalent product. Nucleotide changes which result in alteration of the N-terminal and C-terminal portions of the protein molecule would also not be expected to alter the activity of the protein. Each of the proposed modifications is well within the routine skill in the art, as is determination of retention of biological activity of the encoded products. Moreover, the skilled artisan recognizes that substantially similar sequences encompassed by this invention are also defined by their ability to hybridize, under stringent conditions (0.1X SSC, 0.1% SDS, 65 °C), with the sequences exemplified herein. Preferred substantially similar nucleic acid fragments of the instant invention are those nucleic acid fragments whose DNA sequences are at least 80% identical to the DNA sequence of the nucleic acid fragments reported herein. More preferred nucleic acid fragments are at least 90% identical to the identical to the DNA sequence of the nucleic acid fragments reported herein. Most preferred are nucleic acid fragments that are at least 95% identical to the DNA sequence of the nucleic acid fragments reported herein. A nucleic acid molecule is "hybridizable" to another nucleic acid molecule, such as a cDNA, genomic DNA, or RNA, when a single stranded form of the nucleic acid molecule can anneal to the other nucleic acid molecule under the appropriate conditions of temperature and solution ionic strength. Hybridization and washing conditions are well known and exemplified in Sambrook, J., Fritsch, E. F. and Maniatis, T. Molecular Cloning: A Laboratory Manual. Second Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor (1989), particularly Chapter 11 and Table 11.1 therein (entirely incorporated herein by reference). The conditions of temperature and ionic strength determine the "stringency" of the hybridization. For preliminary screening for homologous nucleic acids, low stringency hybridization conditions, corresponding to a Υm of 55°, can be used, e.g. , 5X SSC, 0.1 % SDS, 0.25% milk, and no formamide; or 30% formamide, 5X SSC, 0.5% SDS. Moderate stringency hybridization conditions correspond to a higher Υm, e.g., 40% formamide, with 5X or 6X SSC. Hybridization requires that the two nucleic acids contain complementary sequences, although depending on the stringency of the hybridization, mismatches between bases are possible. The appropriate stringency for hybridizing nucleic acids depends on the length of the nucleic acids and the degree of complementation, variables well known in the art. The greater the degree of similarity or homology between two nucleotide sequences, the greater the value of Υm for hybrids of nucleic acids having those sequences. The relative stability (corresponding to higher Tm) of nucleic acid hybridizations decreases in the following order: RNA: RNA, DNA: RNA, DNA:DNA. For hybrids of greater than 100 nucleotides in length, equations for calculating Υm have been derived (see Sambrook et al., supra, 9.50-9.51). For hybridizations with shorter nucleic acids, i.e., oligonucleotides, the position of mismatches becomes more important, and the length of the oligonucleotide determines its specificity (see Sambrook et al., supra, 11.7-11.8). In one embodiment the length for a hybridizable nucleic acid is at least about 10 nucleotides. Preferable a minimum length for a hybridizable nucleic acid is at least about 15 nucleotides; more preferably at least about 20 nucleotides; and most preferably the length is at least 30 nucleotides. Furthermore, the skilled artisan will recognize that the temperature and wash solution salt concentration may be adjusted as necessary according to factors such as length of the probe. A "substantial portion" of an amino acid or nucleotide sequence comprising enough of the amino acid sequence of a polypeptide or the nucleotide sequence of a gene to putatively identify that polypeptide or gene, either by manual evaluation of the sequence by one skilled in the art, or by computer- automated sequence comparison and identification using algorithms such as BLAST (Basic Local Alignment Search Tool; Altschul, S. F., et al., (1993) J. Mol. Biol. 215:403-410; see also www.ncbi.nlm.nih.gov/BLAST/). In general, a sequence often or more contiguous amino acids or thirty or more nucleotides is necessary in order to putatively identify a polypeptide or nucleic acid sequence as homologous to a known protein or gene. Moreover, with respect to nucleotide sequences, gene specific oligonucleotide probes comprising 20-30 contiguous nucleotides may be used in sequence-dependent methods of gene identification (e.g., Southern hybridization) and isolation (e.g., in situ hybridization of bacterial colonies or bacteriophage plaques). In addition, short oligonucleotides of 12-15 bases may be used as amplification primers in PCR in order to obtain a particular nucleic acid fragment comprising the primers. Accordingly, a "substantial portion" of a nucleotide sequence comprises enough of the sequence to specifically identify and/or isolate a nucleic acid fragment comprising the sequence. The instant specification teaches partial or complete amino acid and nucleotide sequences encoding one or more particular fungal proteins. The skilled artisan, having the benefit of the sequences as reported herein, may now use all or a substantial portion of the disclosed sequences for purposes known to those skilled in this art. Accordingly, the instant invention comprises the complete sequences as reported in the accompanying Sequence Listing, as well as substantial portions of those sequences as defined above. The term "percent identity", as known in the art, is a relationship between two or more polypeptide sequences or two or more polynucleotide sequences, as determined by comparing the sequences. In the art, "identity" also means the degree of sequence relatedness between polypeptide or polynucleotide sequences, as the case may be, as determined by the match between strings of such sequences. "Identity" and "similarity" can be readily calculated by known methods, including but not limited to those described in: Computational Molecular Biology (Lesk, A. M., ed.) Oxford University Press, New York (1988); Biocomputing: Informatics and Genome Projects (Smith, D. W., ed.) Academic Press, New York (1993); Computer Analysis of Sequence Data, Part I (Griffin, A. M., and Griffin, H. G., eds.) Humana Press, New Jersey (1994); Sequence Analysis in Molecular Biology (von Heinje, G., ed.) Academic Press (1987); and Sequence Analysis Primer (Gribskov, M. and Devereux, J., eds.) Stockton Press, New York (1991). Preferred methods to determine identity are designed to give the largest match between the sequences tested. Methods to determine identity and similarity are codified in publicly available computer programs. Preferred computer program methods to determine identity and similarity between two sequences include, but are not limited to, the GCG Pileup program found in the GCG program package, as used in the instant invention, using the Needleman and Wunsch algorithm with their standard default values of gap creation penalty=12 and gap extension penalty=4 (Devereux et al, Nucleic Acids Res. 12:387-395 (1984)), BLASTP, BLASTN, and FASTA (Pearson et al., Proc. Natl. Acad. Sci. U.S.A. 85:2444-2448 (1988). The BLAST X program is publicly available from NCBI and other sources (BLAST Manual Altschul et al, Natl. Cent. Biotechnol. Inf., Natl. Library Med. (NCBI NLM) NIH, Bethesda, Md. 20894; Altschul et al, J. Mol Biol. 215:403-410 (1990)). Another preferred method to determine percent identity, is by the method of DNASTAR protein alignment protocol using the Jotun-Hein algorithm (Hein et al., Methods Enzymol. 183:626-645 (1990)). Default parameters for the Jotun-Hein method for alignments are: for multiple alignments, gap penalty=l 1, gap length penalty=3; for pairwise alignments ktuple=6. As an illustration, by a polynucleotide having a nucleotide sequence having at least, for example, 95% "identity" to a reference nucleotide sequence of SEQ ID NO: 1 it is intended that the nucleotide sequence of the polynucleotide is identical to the reference sequence except that the polynucleotide sequence may include up to five point mutations per each 100 nucleotides of the reference nucleotide sequence of SEQ ID NO: 1. In other words, to obtain a polynucleotide having a nucleotide sequence at least 95% identical to a reference nucleotide sequence, up to 5% of the nucleotides in the reference sequence may be deleted or substituted with another nucleotide, or a number of nucleotides up to 5% of the total nucleotides in the reference sequence may be inserted into the reference sequence. These mutations of the reference sequence may occur at the 5' or 3' terminal positions of the reference nucleotide sequence or anywhere between those terminal positions, interspersed either individually among nucleotides in the reference sequence or in one or more contiguous groups within the reference sequence. Analogously, by a polypeptide having an amino acid sequence having at least, for example, 95% identity to a reference amino acid sequence of SEQ ID NO:2 is intended that the amino acid sequence of the polypeptide is identical to the reference sequence except that the polypeptide sequence may include up to five amino acid alterations per each 100 amino acids of the reference amino acid of SEQ ID NO:2. In other words, to obtain a polypeptide having an amino acid sequence at least 95% identical to a reference amino acid sequence, up to 5% of the amino acid residues in the reference sequence may be deleted or substituted with another amino acid, or a number of amino acids up to 5% of the total amino acid residues in the reference sequence may be inserted into the reference sequence. These alterations of the reference sequence may occur at the amino or carboxy terminal positions of the reference amino acid sequence or anywhere between those terminal positions, interspersed either individually among residues in the reference sequence or in one or more contiguous groups within the reference sequence. The term "complementary" is used to describe the relationship between nucleotide bases that are capable to hybridizing to one another. For example, with respect to DNA, adenosine is complementary to thymine and cytosine is complementary to guanine. Accordingly, the instant invention also includes isolated nucleic acid fragments that are complementary to the complete sequences as reported in the accompanying Sequence Listing as well as those substantially similar nucleic acid sequences. "Codon degeneracy" refers to divergence in the genetic code permitting variation of the nucleotide sequence without effecting the amino acid sequence of an encoded polypeptide. Accordingly, the instant invention relates to any nucleic acid fragment that encodes all or a substantial portion of the amino acid sequence encoding the GST enzymes as set forth in SEQ ID Nos: SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO.12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO:20, SEQ ID NO:22, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:38, SEQ ID NO:40, SEQ ID NO:42, SEQ ID NO:44, SEQ ID NO:46, SEQ ID NO:48, SEQ ID NO:50, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72 and SEQ ID NO:74. The skilled artisan is well aware of the "codon-bias" exhibited by a specific host cell in usage of nucleotide codons to specify a given amino acid. Therefore, when synthesizing a gene for improved expression in a host cell, it is desirable to design the gene such that its frequency of codon usage approaches the frequency of preferred codon usage of the host cell. "Synthetic genes" can be assembled from oligonucleotide building blocks that are chemically synthesized using procedures known to those skilled in the art. These building blocks are ligated and annealed to form gene segments which are then enzymatically assembled to construct the entire gene. "Chemically synthesized", as related to a sequence of DNA, means that the component nucleotides were assembled in vitro. Manual chemical synthesis of DNA may be accomplished using well established procedures, or automated chemical synthesis can be performed using one of a number of commercially available machines. Accordingly, the genes can be tailored for optimal gene expression based on optimization of nucleotide sequence to reflect the codon bias of the host cell. The skilled artisan appreciates the likelihood of successful gene expression if codon usage is biased towards those codons favored by the host. Determination of preferred codons can be based on a survey of genes derived from the host cell where sequence information is available. "Gene" refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5' non-coding sequences) and following (3' non-coding sequences) the coding sequence. "Native gene" refers to a gene as found in nature with its own regulatory sequences. "Chimeric gene" refers any gene that is not a native gene, comprising regulatory and coding sequences that are not found together in nature. Accordingly, a chimeric gene may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source, but arranged in a manner different than that found in nature. "Endogenous gene" refers to a native gene in its natural location in the genome of an organism. A "foreign" gene refers to a gene not normally found in the host organism, but that is introduced into the host organism by gene transfer. Foreign genes can comprise native genes inserted into a non-native organism, or chimeric genes. A "transgene" is a gene that has been introduced into the genome by a transformation procedure. "Coding sequence" refers to a DNA sequence that codes for a specific amino acid sequence. "Suitable regulatory sequences" refer to nucleotide sequences located upstream (5' non-coding sequences), within, or downstream (3' non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences may include promoters, translation leader sequences, introns, and polyadenylation recognition sequences. "Promoter" refers to a DNA sequence capable of controlling the expression of a coding sequence or functional RNA. In general, a coding sequence is located 3' to a promoter sequence. The promoter sequence consists of proximal and more distal upstream elements, the latter elements often referred to as enhancers. Accordingly, an "enhancer" is a DNA sequence which can stimulate promoter activity and may be an innate element of the promoter or a heterologous element inserted to enhance the level or tissue-specificity of a promoter. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic DNA segments. It is understood by those skilled in the art that different promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions. Promoters which cause a gene to be expressed in most cell types at most times are commonly referred to as "constitutive promoters". New promoters of various types useful in plant cells are constantly being discovered; numerous examples may be found in the compilation by Okamuro and Goldberg, (1989) Biochemistry of Plants 15:1-82. It is further recognized that since in most cases the exact boundaries of regulatory sequences have not been completely defined, DNA fragments of different lengths may have identical promoter activity. The "translation leader sequence" refers to a DNA sequence located between the promoter sequence of a gene and the coding sequence. The translation leader sequence is present in the fully processed mRNA upstream of the translation start sequence. The translation leader sequence may affect processing of the primary transcript to mRNA, mRNA stability or translation efficiency. Examples of translation leader sequences have been described (Turner, R. and Foster, G. D. (1995) Molecular Biotechnology 5:225). The "3' non-coding sequences" refer to DNA sequences located downstream of a coding sequence and include polyadenylation recognition sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression. The polyadenylation signal is usually characterized by affecting the addition of poly adeny lie acid tracts to the 3' end of the mRNA precursor. The use of different 3' non-coding sequences is exemplified by Ingelbrecht et al. ((1989) Plant Cell 7:671-680). "RNA transcript" refers to the product resulting from RNA polymerase- catalyzed transcription of a DNA sequence. When the RNA transcript is a perfect complementary copy of the DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived from posttranscriptional processing of the primary transcript and is referred to as the mature RNA. "Messenger RNA (mRNA)" refers to the RNA that is without introns and that can be translated into protein by the cell. "cDNA" refers to a double-stranded DNA that is complementary to and derived from mRNA. "Sense" RNA refers to RNA transcript that includes the mRNA and so can be translated into protein by the cell. "Antisense RNA" refers to a RNA transcript that is complementary to all or part of a target primary transcript or mRNA and that blocks the expression of a target gene (U.S. Pat. No. 5,107,065). The complementarity of an antisense RNA may be with any part of the specific gene transcript, i.e., at the 5' non-coding sequence, 3' non-coding sequence, introns, or the coding sequence. "Functional RNA" refers to antisense RNA, ribozyme RNA, or other RNA that is not translated yet has an effect on cellular processes. The term "operably linked" refers to the association of nucleic acid sequences on a single nucleic acid fragment so that the function of one is affected by the other. For example, a promoter is operably linked with a coding sequence when it is capable of affecting the expression of that coding sequence (i.e., that the coding sequence is under the transcriptional control of the promoter). Coding sequences can be operably linked to regulatory sequences in sense or antisense orientation. The term "expression", as used herein, refers to the transcription and stable accumulation of sense (mRNA) or antisense RNA derived from the nucleic acid fragment of the invention. Expression may also refer to translation of mRNA into a polypeptide. "Antisense inhibition" refers to the production of antisense RNA transcripts capable of suppressing the expression of the target protein. "Overexpression" refers to the production of a gene product in transgenic organisms that exceeds levels of production in normal or non-transformed organisms. "Co-suppression" refers to the production of sense RNA transcripts capable of suppressing the expression of identical or substantially similar foreign or endogenous genes (U.S. Pat. No. 5,231 ,020). "Altered levels" refers to the production of gene product(s) in transgenic organisms in amounts or proportions that differ from that of normal or non- transformed organisms. "Mature" protein refers to a post-translationally processed polypeptide; i.e., one from which any pre- or propeptides present in the primary translation product have been removed. "Precursor" protein refers to the primary product of translation of mRNA; i.e., with pre- and propeptides still present. Pre- and propeptides may be but are not limited to intracellular localization signals. A "chloroplast transit peptide" is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the chloroplast or other plastid types present in the cell in which the protein is made. "Chloroplast transit sequence" refers to a nucleotide sequence that encodes a chloroplast transit peptide. A "signal peptide" is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the secretory system (Chrispeels, J.J., (1991) Ann. Rev. Plant Phys. Plant Mol. Biol 42:21-53). If the protein is to be directed to a vacuole, a vacuolar targeting signal (supra) can further be added, or if to the endoplasmic reticulum, an endoplasmic reticulum retention signal (supra) may be added. If the protein is to be directed to the nucleus, any signal peptide present should be removed and instead a nuclear localization signal included (Raikhel (1992) Plant Phys.l 00: 1627- 1632). "Transformation" refers to the transfer of a nucleic acid fragment into the genome of a host organism, resulting in genetically stable inheritance. Host organisms containing the transformed nucleic acid fragments are referred to as "transgenic" organisms. Examples of methods of plant transformation include Agrobacterium-mediated transformation (De Blaere et al. (1987) Meth. Enzymol. 143:211) and particle-accelerated or "gene gun" transformation technology (Klein et al. (1987) Nature (London) 527:70-73; U.S. Pat. No. 4,945,050). The term "herbicide-tolerant plant" as used herein is defined as a plant that survives and preferably grows normally at a usually effective dose of a herbicide. Herbicide tolerance in plants according to the present invention refers to detoxification mechanisms in a plant, although the herbicide binding or target site is still sensitive. "Thiol donor" refers to a compound that contains the structure RSH (where R is not equal to H). Within the context of the present invention suitable thiol donors may include, but are not limited to, Glutathione and homoglutathione. "Electrophilic substrate" refers to a compound that is amenable to conjugation with glutathione or homoglutathione via a sulfhydryl group. Electrophilic substrates include a wide variety of compounds including pesticides, anti-pathogenic compounds such as fungicides and profungicides, pheramones, and herbicides. Within the context of the present invention electrophilic substrates with herbicidal activity may include, but are not limited to, chlorimuronethyl, alachlor, and atrazine, l-chloro-2,4-dinitrobenzene (CDNB), ethacrynic acid, t-stilbene oxide, and l,2-epoxy-3-(p-nitrophenoxy)propane. Standard recombinant DNA and molecular cloning techniques used herein are well known in the art and are described more fully in Sambrook, J., Fritsch, E. F. and Maniatis, T. Molecular Cloning: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989 (hereinafter "Maniatis"). "Thiol donor" refers to a compound that contains the structure RSH (where R is not equal to H). Within the context of the present invention suitable thiol donors may include, but are not limited to, Glutathione and homoglutathione. "Electrophilic substrate" refers to a compound that is amenable to conjugation with glutathione or homoglutathione via a sulfhydryl group. Electrophilic substrates include a wide variety of compounds including pesticides, anti-pathogenic compounds such as fungicides and profungicides, pheramones, and herbicides. Within the context of the present invention electrophilic substrates with herbicidal activity may include, but are not limited to, chlorimuronethyl, alachlor, and atrazine, l-chloro-2,4-dinitrobenzene (CDNB), ethacrynic acid, t-stilbene oxide, and l,2-epoxy-3-(p-nitrophenoxy)propane. The nucleic acid fragments of the instant invention may be used to isolate cDNAs and genes encoding homologous enzymes from the same or other plant species. Isolation of homologous genes using sequence-dependent protocols is well known in the art. Examples of sequence-dependent protocols include, but are not limited to, methods of nucleic acid hybridization, and methods of DNA and RNA amplification as exemplified by various uses of nucleic acid amplification technologies (e.g., polymerase chain reaction, ligase chain reaction). For example, genes encoding other GST enzymes, either as cDNAs or genomic DNAs, could be isolated directly by using all or a portion of the instant nucleic acid fragments as DNA hybridization probes to screen libraries from any desired plant using methodology well known to those skilled in the art. Specific oligonucleotide probes based upon the instant nucleic acid sequences can be designed and synthesized by methods known in the art (Maniatis). Moreover, the entire sequences can be used directly to synthesize DNA probes by methods known to the skilled artisan such as random primers DNA labeling, nick translation, or end-labeling techniques, or RNA probes using available in vitro transcription systems. In addition, specific primers can be designed and used to amplify a part of or full-length of the instant sequences. The resulting amplification products can be labeled directly during amplification reactions or labeled after amplification reactions, and used as probes to isolate full length cDNA or genomic fragments under conditions of appropriate stringency. In addition, two short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols to amplify longer nucleic acid fragments encoding homologous genes from DNA or RNA. The polymerase chain reaction may also be performed on a library of cloned nucleic acid fragments wherein the sequence of one primer is derived from the instant nucleic acid fragments, and the sequence of the other primer takes advantage of the presence of the polyadenylic acid tracts to the 3' end of the mRNA precursor encoding plant genes. Alternatively, the second primer sequence may be based upon sequences derived from the cloning vector. For example, the skilled artisan can follow the RACE protocol (Frohman et al., (1988) PNAS USA 55:8998) to generate cDNAs by using PCR to amplify copies of the region between a single point in the transcript and the 3' or 5' end. Primers oriented in the 3' and 5' directions can be designed from the instant sequences. Using commercially available 3' RACE or 5* RACE systems (BRL), specific 3' or 5' cDNA fragments can be isolated (Ohara et al., (1989) PNAS USA 86:5613; Loh et al., (1989) Science 243:211). Products generated by the 3' and 5' RACE procedures can be combined to generate full-length cDNAs (Frohman, M. A. and Martin, G. R., (1989) Techniques 7:165). Availability of the instant nucleotide and deduced amino acid sequences facilitates immunological screening cDNA expression libraries. Synthetic peptides representing portions of the instant amino acid sequences may be synthesized. These peptides can be used to immunize animals to produce polyclonal or monoclonal antibodies with specificity for peptides or proteins comprising the amino acid sequences. These antibodies can be then be used to screen cDNA expression libraries to isolate full-length cDNA clones of interest (Lerner, R. A. (1984) Adv. Immunol. 36:1; Maniatis). The nucleic acid fragments of the instant invention may be used to create transgenic plants in which the disclosed GST enzymes are present at higher or lower levels than normal or in cell types or developmental stages in which they are not normally found. This would have the effect of altering the level of GST enzyme available as well as the herbicide tolerant-phenotype of the plant. Overexpression of the GST enzymes of the instant invention may be accomplished by first constructing chimeric genes in which the coding region are operably linked to promoters capable of directing expression of a gene in the desired tissues at the desired stage of development. For reasons of convenience, the chimeric genes may comprise promoter sequences and translation leader sequences derived from the same genes. 3' Non-coding sequences encoding transcription termination signals must also be provided. The instant chimeric genes may also comprise one or more introns in order to facilitate gene expression. Any combination of any promoter and any terminator capable of inducing expression of a GST coding region may be used in the chimeric genetic sequence. Some suitable examples of promoters and terminators include those from nopaline synthase (nos), octopine synthase (ocs) and cauliflower mosaic virus (CaMV) genes. One type of efficient plant promoter that may be used is a high level plant promoter. Such promoters, in operable linkage with the genetic sequence for GST, should be capable of promoting expression of the GST such that the transformed plant is tolerant to an herbicide due to the presence of, or increased levels of, GST enzymatic activity. High level plant promoters that may be used in this invention include the promoter of the small subunit (ss) of the ribulose-1,5- bisphosphate carboxylase from example from soybean (Berry-Lowe et al., J. Molecular andApp. Gen., 1 :483-498 1982)), and the promoter of the chlorophyll a/b binding protein. These two promoters are known to be light- induced in plant cells (See, for example, Genetic Engineering of Plants, an Agricultural Perspective. A. Cashmore, Plenum, New York (1983), pages 29-38; Coruzzi, G. et al., The Journal of Biological Chemistry, 258:1399 (1983), and Dunsmuir, P. et al., Journal of Molecular and Applied Genetics, 2:285 (1983)). Plasmid vectors comprising the instant chimeric genes can then constructed. The choice of plasmid vector depends upon the method that will be used to transform host plants. The skilled artisan is well aware of the genetic elements that must be present on the plasmid vector in order to successfully transform, select and propagate host cells containing the chimeric gene. The skilled artisan will also recognize that different independent transformation events will result in different levels and patterns of expression (Jones et al., (1985) EMBO J. 4:2411-2418; De Almeida et al., (1989) Mol. Gen. Genetics 275:78-86), and thus that multiple events must be screened in order to obtain lines displaying the desired expression level and pattern. Such screening may be accomplished by Southern analysis of DNA blots (Southern, J. Mol. Biol. 98, 503, (1975)). Northern analysis of mRNA expression (Kroczek, J. Chromatogr. Biomed. App , 618 (1-2) (1993) 133-145), Western analysis of protein expression, or phenotypic analysis. For some applications it will be useful to direct the instant GST enzymes to different cellular compartments or to facilitate enzyme secretion from a recombinant host cell. It is thus envisioned that the chimeric genes described above may be further supplemented by altering the coding sequences to encode enzymes with appropriate intracellular targeting sequences such as transit sequences (Keegstra, K., Cell 56:241-253 (1989)), signal sequences or sequences encoding endoplasmic reticulum localization (Chrispeels, J. J., Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53 (1991)), or nuclear localization signals (Raikhel, N. Plant Phys. 100:1621-1632 (1992)) added and/or with targeting sequences that are already present removed. While the references cited give examples of each of these, the list is not exhaustive and more targeting signals of utility may be discovered in the future that are useful in the invention. It may also be desirable to reduce or eliminate expression of the genes encoding the instant GST enzymes in plants for some applications. In order to accomplish this, chimeric genes designed for co-suppression of the instant GST enzymes can be constructed by linking the genes or gene fragments encoding the enzymes to plant promoter sequences. Alternatively, chimeric genes designed to express antisense RNA for all or part of the instant nucleic acid fragments can be constructed by linking the genes or gene fragment in reverse orientation to plant promoter sequences. Either the co-suppression or antisense chimeric genes could be introduced into plants via transformation wherein expression of the corresponding endogenous genes are reduced or eliminated. Plants transformed with the present GST genes will have a variety of phenotypes corresponding to the various properties conveyed by the GST class of proteins. Glutathione conjugation catalyzed by GSTs is known to result in sequestration and detoxification of a number of herbicides and other xenobiotics (Marrs eX a ., Annu. Rev. Plant Physiol. Plant Mol. Biol. 47:127-58 (1996)) and thus will be expected to produce transgenic plants with this phenotype. Other GST proteins are known to be induced by various environmental stresses such as salt stress (Roxas, et al., Stress tolerance in transgenic seedlings that overexpress glutathione S-transferase, Annual Meeting of the American Society of Plant Physiologists, (August 1997), abstract 1574, Final Program, Plant Biology and Supplement to Plant Physiology, 301), exposure to ozone (Sharma et al, Plant Physiology, 105 (4) (1994) 1089-1096), and exposure to industrial pollutants such as sulfur dioxide (Navari-Izzo et al., Plant Science 96 (1-2) (1994) 31-40). It is contemplated that transgenic plants, tolerant to a wide variety of stresses, may be produced by the present method by expressing foreign GST genes in suitable plant hosts. The instant GST enzymes produced in heterologous host cells, particularly in the cells of microbial hosts, can be used to prepare antibodies to the enzymes by methods well known to those skilled in the art. The antibodies are useful for detecting the enzymes in situ in cells or in vitro in cell extracts. Preferred heterologous host cells for production of the instant GST enzymes are microbial hosts. Microbial expression systems and expression vectors containing regulatory sequences that direct high level expression of foreign proteins are well known to those skilled in the art. Any of these could be used to construct chimeric genes for production of the instant GST enzymes. These chimeric genes could then be introduced into appropriate microorganisms via transformation to provide high level expression of the enzymes. Vectors or cassettes useful for the transformation of suitable host cells are well known in the art. Typically the vector or cassette contains sequences directing transcription and translation of the relevant gene, a selectable marker, and sequences allowing autonomous replication or chromosomal integration. Suitable vectors comprise a region 5' of the gene which harbors transcriptional initiation controls and a region 3' of the DNA fragment which controls transcriptional termination. It is most preferred when both control regions are derived from genes homologous to the transformed host cell, although it is to be understood that such control regions need not be derived from the genes native to the specific species chosen as a production host. Initiation control regions or promoters, which are useful to drive expression of the genes encoding the GST enzymes in the desired host cell are numerous and familiar to those skilled in the art. Virtually any promoter capable of driving these genes is suitable for the present invention including but not limited to CYC1, HIS3, GAL1, GAL10, ADH1, PGK, PHO5, GAPDH, ADC1, TRP1, URA3, LEU2, ENO, TPI (useful for expression in Saccharomyces); AOX1 (useful for expression in Pichia); and lac, tip, P-^, λP R , T7, tac, and trc (useful for expression in E. colϊ). Termination control regions may also be derived from various genes native to the preferred hosts. Optionally, a termination site may be unnecessary, however, it is most preferred if included. An example of a vector for high level expression of the instant GST enzymes in a bacterial host is provided (Example 5). Additionally, the instant maize GST enzymes can be used as a targets to facilitate design and/or identification of inhibitors of the enzymes that may be useful as herbicides or herbicide synergists. This is desirable because the enzymes described herein catalyze the sulfhydryl conjugation of glutathione to compounds toxic to the plant. Conjugation can result in detoxification of these compounds. It is likely that inhibition of the detoxification process will result in inhibition of plant growth or plant death. Thus, the instant maize GST enzymes could be appropriate for new herbicide or herbicide synergist discovery and design. All or a portion of the nucleic acid fragments of the instant invention may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to expression of the instant enzymes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes or in the identification of mutants. For example, the instant nucleic acid fragments may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Maniatis) of restriction-digested plant genomic DNA may be probed with the nucleic acid fragments of the instant invention. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et at., (1987) Genomics 7:174-181) in order to construct a genetic map. In addition, the nucleic acid fragments of the instant invention may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the instant nucleic acid sequence in the genetic map previously obtained using this population (Botstein et al., (1980) Am. J. Hum. Genet. 52:314-331). The production and use of plant gene-derived probes for use in genetic mapping are described by Bernatzky, R. and Tanksley, S. D. (Plant Mol. Biol. Reporter 4(l):31-4l (1986)). Numerous publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art. Nucleic acid probes derived from the instant nucleic acid sequences may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al., In: Nonmammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein). In another embodiment, nucleic acid probes derived from the instant nucleic acid sequences may be used in direct fluorescence in situ hybridization (FISH) mapping. Although current methods of FISH mapping favor use of large clones (several to several hundred KB), improvements in sensitivity may allow performance of FISH mapping using shorter probes. A variety of nucleic acid amplification-based methods of genetic and physical mapping may be carried out using the instant nucleic acid sequences. Examples include allele-specific amplification, polymorphism of PCR-amplified fragments (CAPS), allele-specific ligation, nucleotide extension reactions, Radiation Hybrid Mapping and Happy Mapping. For these methods, the sequence of a nucleic acid fragment is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR- based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, this is generally not necessary for mapping methods. Such information may be useful in plant breeding in order to develop lines with desired starch phenotypes. EXAMPLES The present invention is further defined in the following Examples, in which all parts and percentages are by weight and degrees are Celsius, unless otherwise stated. It should be understood that these Examples, while indicating preferred embodiments of the invention, are given by way of illustration only. From the above discussion and these Examples, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions. GENERAL METHODS Standard recombinant DNA and molecular cloning techniques used in the Examples are well known in the art and are described by Sambrook, J. , Fritsch, E. F. and Maniatis, T. Molecular Cloning: A Laboratory Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, (1989) (Maniatis) and by T. J. Silhavy, M. L. Bennan, and L. W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. (1984) and by Ausubel, F. M. et al., Current Protocols in Molecular Biology, pub. by Greene Publishing Assoc. and Wiley-Interscience (1987). EXAMPLE 1 Composition of cDNA Libraries; Isolation and Sequencing of cDNA Clones cDNA libraries representing mRNAs from various maize tissues were prepared. The characteristics of the libraries are described in Table 1. TABLE 1 cDNA Libraries From Corn Tissues GST Library Class Clone Tissue bmsl I bmsl.pk0023.g8 Maize BMS cell culture 1 day after subculture csl I csl.pk0010.c5 Maize leaf, sheath 5 wk plant Stratogene #837201 cebl I cebl.pk0017.a5 Maize embryo cc71se III cc71se-a.pk0001.g2 Maize class II callus tissue, somatic embryo formed, highly transformable cc71.se III cc71se-b.pk0014.b8 Maize class II callus tissue, somatic embryo formed, highly transformable ceb5 III ceb5.pk0051.ffi Amplified maize embryo 30 day crln III crln.pk0003.bl Maize root from 7 day seedlings grown in light normalized crln III crln.pk0014.g8 Maize root from 7 day seedlings grown in light normalized m II m.l5.5.d06.sk20 Maize 15 day embryo library crln II crln.pk0040.el2 Maize root from 7 day seedlings grown in light normalized ceb5 III ceb5.pk0049.al 1 Amplified maize embryo 30 day csl III csl.pk0059.e2 Maize leaf, sheath 5 wk plant Stratogene #837201 cbn2 gstl Cbn2.pk0032.dl0 Corn (Zea mays L.) developing kernel two days after pollination crln gstl crln.pk0164.g7 Corn (Zea mays L.) root from 7 day seedlings grown in light normalized cdt2 gstl cdt2c.pk003.115 Corn (Zea mays L.) developing tassel 2 csclc gstl csclc.pk001.h7 Corn (Zea mays L., B73) 20 day seedling (germination cold stress). The seedling appeared purple. pOHO gstl p0110.cgsnt78r Corn (Zea mays L. B73) salacylic acid infiltrated V3/V4 leaf tissue (minus midrib), screened 1 pool of A63+SA 4h; A63 +SA 24hr; and A63 + SA 7 days . p0121 gstl p0121.cfrmz42r Corn (Zea mays L.) shank tissue collected from ears 5DAP, Screened 1 csiln gst III csiln.pk0034.al l Corn (Zea mays L.) silk; normalized from csil library cepe7 gst III ceρe7.pk0028.g3 Corn (Zea mays L.) epicotyl from 7 day old etiolated seedling GST Library Class Clone Tissue crln gst III crln.pk0167.d7 Corn (Zea mays L.) root from 7 day seedlings grown in light normalized ccol gst III ccol.pk0027.e4 Corn (Zea mays L.) cob of 67 day old plants grown in green house cpjlc gst III cpjlc.pk001.d21 Corn (Zea mays L.) pooled black mexican sweetcorn treated with chemicals related to membrane ionic force cselc gst III cselc.pk001.b8 Corn (Zea mays L.) seedling at V2 stage treated with Ethylene collected at 6 hr, 23 hr, 72 hr crls gst III crls.pk010.fl Corn (Zea mays L., Lhl32) root from 7 day old etiolated seedlings cpflc gst III cpflc.pk002.al3 Corn (Zea mays L.) pooled black mexican sweetcorn treated with chemicals related to protein synthesis cholc gst III cholc.pk004.cl5 Corn (Zea mays L., Alexho Synthetic High Oil) embryo 20 DAP cpilc gst III cpilc.pk002.m4 Corn (Zea mays L.) pooled black mexican sweetcorn treated with chemicals related to biochemical compound synthesis chpc8 gst III chpc8.pk057.fl0 Corn (Zea mays L., MBS847) 8 day old shoot treated with PDO herbicide MK593 collected 8 hrs after treatment. p0014 gst III p0014.ctu90r Corn (Zea mays L.) Leaf: Gene uazl51 (G- Protein), 413-8, no genetic lesions are formed. C. heterostrophus resistance, plant 3 ft tall, leaf 7 and leaf 8 p0006 gst III p0006.cbyvs55r Corn (Zea mays L.) Young shoot p0037 gst III p0037.crwaf68r Corn (Zea mays L.) corn Root Worm infested V5 roots p0032 gst III p0032.crcas61r Corn (Zea mays L.) Regenernerating callus, 10 and 14 days after auxin removal. Hi-II callus 223a, 1129e 10 days. Hi-II callus 223a, 1129e 14 days p0088 gst III p0088.clrim45r Corn (Zea mays L.) Gene M1C07 (leucine-rich repeat), family 3-B7. about one month after planting in green house p0126 gst III p0126.cnlag50r Corn (Zea mays L.) Night harvested leaf tissue; V8-V10 p0095 gst III p0095.cwsba73r Corn (Zea mays L.) Ear leaf sheath, screened 1 Growth conditions: field; control or untreated tissues Growth stage: 2-3 weeks after pollen shed; plants were allowed to pollinate naturally p0125 gst III p0125.czaaj03r Corn (Zea mays L.) Anther: Prophase I sceened 1 cDNA libraries were prepared in Uni-ZAP™ XR vectors according to the manufacturer's protocol (Stratagene Cloning Systems, La Jolla, CA). The Uni-ZAP™ XR libraries were converted into plasmid libraries according to the protocol provided by Stratagene. Upon conversion, cDNA inserts were contained in the plasmid vector pBluescript. cDNA inserts from randomly picked bacterial colonies containing recombinant pBluescript plasmids were amplified via polymerase chain reaction using primers specific for vector sequences flanking the inserted cDNA sequences. Amplified insert DNAs were sequenced in dye-primer sequencing reactions to generate partial cDNA sequences (expressed sequence tags or "ESTs"; see Adams, M. D. et al., (1991) Science 252:1651). The resulting ESTs were analyzed using a Perkin Elmer Model 377 fluorescent sequencer. EXAMPLE 2 Identification and Characterization of cDNA Clones cDNAs encoding maize GST enzymes were identified by conducting BLAST (Basic Local Alignment Search Tool; Altschul, S. F., et al., (1993) J. Mol. Biol. 215:403-410; see also www.ncbi.nlm.nih.gov/BLAST/) searches for similarity to sequences contained in the BLAST "nr" database (comprising all non-redundant GenBank CDS translations, sequences derived from the 3-dimensional structure Brookhaven Protein Data Bank, SWISS-PROT prς>tein sequence database, EMBL, and DDBJ databases). The cDNA sequences obtained in Example 1 were analyzed for similarity to all publicly available DNA sequences contained in the "nr" database using the BLASTN algorithm provided by the National Center for Biotechnology Information (NCBI). The DNA sequences were translated in all reading frames and compared for similarity to all publicly available protein sequences contained in the "nr" database using the BLASTX algorithm (Gish, W. and States, D. J. (1993) Nature Genetics 5:266-272) provided by the NCBI. For convenience, the P-value (probability) of observing a match of a cDNA sequence to a sequence contained in the searched databases merely by chance as calculated by BLAST are reported herein as "pLog" values, which represent the negative of the logarithm of the reported P-value. Accordingly, the greater the pLog value, the greater the likelihood that the cDNA sequence and the BLAST "hit" represent homologous proteins. All comparisons were done using either the BLASTNnr or BLASTXnr algorithms. The results of the BLAST comparisons are given in Table 2 and summarize the clones and the sequences to which they have the most similarity. Table 2 displays data based on the BLASTNnr or BLASTXnr algorithm with values reported in pLogs or Exprect values. The Expect value estimates the statistical significance of the match, specifying the number of matches, with a given score, that are expected in a search of a database of this size absolutely by chance. Each cDNA identified encodes at least a portion of either a GST class I, II, or III. All isolated clones contain a full length open reading frame (ORF) with the exception of cc71se-a.pk0001.g2 which is only a partial clone. Example 5 describes the sequencing strategy for the above described clones. TABLE 2 BLAST Results For Clones SEQ ID NO. GST Blast pLog Clone Class Similarity Identified Base Peptide Algorithm Score*/E- Value** Citation bmsl.pk0023.g8 I X79515|ZMGST27 Z.mays 1 Nnr 122.086 GST-27 mRNA for glutathione-S- transferase csl.pk0010.c5 I D17673|ATHERD13 3 Nnr 8.16 Arabidopsis thaliana mRNA for glutathione S-transferase cebl.pk0017.a5 I X78203|HMGST H. uticus 5 Nnr 21.51 mRNA for glutathione S-transferase cc71se- III (AF004358) glutathione S- 7 Nnr 16.48 a.pk0001.g2 transferase TSI-1 (Aegilops squarrosa) cc71se- III D 1086 l|RICORFC Rice 9 10 Nnr 14.96 mRNA for a protein related to chilling b.pk0014.b8 tolerance. ceb5.pk0051.f8 III D 1086 l|RICORFC Rice 11 12 Nnr 40.44 mRNA for a protein related to chilling tolerance. crln.pk0003.bl III U80615|EGU80615 Eucalyptus 13 14 Nnr 24.70 globulus auxin-induced protein (EgPar) mRNA, complete eds SEQ ID NO. GST Blast pL°g Clone Class Similarity Identified Base Peptide Algorithm Score*/E- Value** Citation crln.pk0014.g8 III M 16901|MZEGSTIB Maize 15 16 Nnr 5.85 glutathione S-transferase (GST-I) mRNA, complete eds m.l5.5.d06.sk20 II |M97702|DROGLUSTD 17 18 Nnr 3.63 Drosophila melanogaster glutathione S-transferase gene. crln.pk0040.el2 II 167970 (L05915) (GST 1 ) gene 19 20 Xnr 42.03 product (Dianthus caryophyllus) ceb5.pk0049.al 1 III |Y12862| ZYMY12862 Zea Maize 21 22 Nnr 0.0 mRNA for glutathione S-transferase csl.pk0059.e2 III D10861|RICORFC Rice mRNA for a 24 25 Nnr 41.03 protein related to chilling tolerance. cbn2.pk0032.dl0 gstl (AC005309) glutathione s-transferase, 25 26 Xnr 4e-27 unpublished GST6 [Arabidopsis thaliana] crln.pk0164.g7 gstl (AC005309) glutathione s-transferase, 27 28 Xnr 7e-37 unpublished GST6 [Arabidopsis thaliana] cdt2c.pk003.115 gstl (AC005309) glutathione s-transferase, 29 30 Xnr 4e-36 unpublished GST6 [Arabidopsis thaliana] csclc.pk001.h7 g gssttll (U70672) glutathione S-transferase 31 32 Xnr 8e-34 unpublished [Arabidopsis thaliana] SEQ ID NO. GST Blast pLog Clone Class Similarity Identified Base Peptide Algorithm Score*/E- Value** Citation p0110.cgsnt78r gstl P464201 GTH4 MAIZE 33 34 Xnr le-97 Plant Mol. Biol. 26 (6), 1855-1866 (1994) GLUTATHIONE S-TRANSFERASE IV (GST-IV) (GST-27) p0121.cfrmz42r. gstl P42761 | GTH3_ARATH 35 36 Xnr 3e-28 ΓJDD ___e ι. JJJ Δ), loy-iy . ιyyo) GLUTATHIONE S-TRANSFERASE ERD13 (CLASS PHI) csiln.pk0034.all gst III Q03664 | GTX3_TOBAC PROBABLE 37 38 Xnr 2e-51 Plant Mol. Biol. 16 (6), 983-998 (199 GLUTATHIONE S-TRANSFERASE (AUXIN-INDUCED PROTEIN PCNT103) cepe7.pk0028.g3 gst III (AF004358) glutathione S-transferase 39 40 Xnr 9e-50 Plant Physiol. 114, 1461-1470 (1997) TSI-1 [Aegilops squarrosa] crln.pk0167.d7 gst III (AF004358) glutathione S-transferase 41 42 Xnr 8e-58 Plant Physiol. 114, 1461-1470 (1997) TSI-1 [Aegilops squarrosa] ccol.pk0027.e4 gst III (Y 12862) glutathione transferase [Zea 43 44 Xnr 2e-77 JOURNAL Plant Mol. Biol. 36, 75- (1998) mays] cpjlc.pk001.d21 gst III | Q03662 | GTX1_TOBAC 45 46 Xnr le-53 Plant Mol. Biol. 16 (6), 983-998 (199 PROBABLE GLUTATHIONE S-TRANSFERASE (AUXIN- INDUCED PROTEIN PGNT1/PCNT110) SEQ ID NO. GST Blast pLog Clone Class Similarity Identified Base Peptide Algorithm Score*/E- Value** Citation cselc.pk001.b8 gst III (AF004358) glutathione S-transferase 47 48 Xnr 3e-62 Plant Physiol. 114, 1461-1470 (1997) TSI-1 [Aegilops squarrosa] crls.pk010.fl gst III P32110|GTX6_SOYBN PROBABLE 49 50 Xnr 4e-49 Mol. Cell. Biol. 8 (3), 1113-1122 (19 GLUTATHIONE S-TRANSFERASE (HEAT SHOCK PROTEIN 26A) cpflc.pk002.al3 gst III Q03662 | GTX1_TOBAC PROBABLE 51 52 Xnr 6e-47 Plant Mol. Biol. 16 (6), 983-998 (199 GLUTATHIONE S-TRANSFERASE (AUXIN-INDUCED PROTEIN PGNT1/PCNT110) cholc.pk004.cl5 gst III (AF004358) glutathione S-transferase 53 54 Xnr le-59 Plant Physiol. 114, 1461-1470 (1997) TSI-1 [Aegilops squarrosa] cpilc.pk002.m4 gst III (AF051214) probable glutathione 55 56 Xnr 7e-45 Genetics 149 (2), 1089-1098 (1998) S-transferase [Picea mariana] chpc8.pk057.fl0 gst III (AJ010449) glutathione transferase 57 58 Xnr le-62 unpublished [Alopecurus myosuroides] p0014.ctu90r gst HI (AJ010448) glutathione transferase 59 60 Xnr 8e-55 unpublished [Alopecurus myosuroides] p0006.cbyvs55r gst III (AF051214) probable glutathione 61 62 Xnr 4e-51 Genetics 149 (2), 1089-1098 (1998) S-transferase [Picea mariana] p0037.crwaf68r gst III (AF004358) glutathione S-transferase 63 64 Xnr 2e-77 Plant Physiol. 114, 1461-1470 (1997) TSI-1 [Aegilops squarrosa] SEQ ID NO. GST Blast pL°g Clone Class Similarity Identified Base Peptide Algorithm Score*/E- Value** Citation p0032.crcas61r gst III P32110 GTX6 SOYBN PROBABLE 65 66 Xnr 3e-48 Mol. Cell. Biol. 8 (3), 1113-1122 (19 GLUTATHIONE S-TRANSFERASE (HEAT SHOCK PROTEIN 26A) p0088.clrim45r gst III (AF004358) glutathione S-transferase 67 68 Xnr 3e-53 Plant Physiol. 114, 1461-1470 (1997) TSI-1 [Aegilops squarrosa] p0126.cnlag50r gst III (AF004358) glutathione S-transferase 69 70 Xnr 4e-52 Plant Physiol. 114, 1461-1470 (1997) TSI-1 [Aegilops squarrosa] p0095.cwsba73r gst III (AF004358) glutathione S-transferase 71 72 Xnr 2e-57 Plant Physiol. 114, 1461-1470 (1997) -> TSI-1 [Aegilops squarrosa] p0125.czaaj03r gst III (AF004358) glutathione S-transferase 73 74 Xnr 7E-63 Plant Physiol. 114, 1461-1470 (1997) TSI-1 [Aegilops squarrosa] * Plog represents the negative of the logarithm of the reported P-value ** Expect value estimates the statistical significance of the match, specifying the number of matches, with a given score, that are expected in a search of a database of this size absolutely chance. EXAMPLE 3 Expression of Chimeric Genes Encoding Maize GST Enzymes in Maize Cells (Monocotyledon) A chimeric gene comprising a cDNA encoding a maize GST enzyme in sense orientation can be constructed by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites (Ncol or Smal) can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the digested vector pML103 as described below. Amplification is then performed in a 100 μL volume in a standard PCR mix consisting of 0.4 mM of each oligonucleotide and 0.3 pM of target DNA in 10 mM Tris-HCl, pH 8.3, 50 mM KC1, 1.5 mM MgCl 2 , 200 mM dGTP, 200 mM dATP, 200 mM dTTP, 200 mM dCTP and 0.025 unit DNA polymerase. Reactions are carried out in a Perkin-Elmer Cetus Thermocycler™ for 30 cycles comprising 1 min at 95 °C, 2 min at 55 °C and 3 min at 72 °C, with a final 7 min extension at 72 °C after the last cycle. The amplified DNA is then digested with restriction enzymes Ncol and Smal and fractionated on a 0.7% low melting point agarose gel in 40 mM Tris-acetate, pH 8.5, 1 mM EDTA. The appropriate band can be excised from the gel, melted at 68 °C and combined with a 4.9 kb Ncol-Smal fragment of the plasmid pML103. Plasmid pML103 has been deposited under the terms of the Budapest Treaty at ATCC (American Type Culture Collection, 12301 Parklawn Drive, Rockville, MD 20852), and bears accession number ATCC 97366. The DNA segment from pML103 contains a 1.05 kb Sall-Ncol promoter fragment of the maize 27 kD zein gene and a 0.96 kb Smal-Sall fragment from the 3' end of the maize 10 kD zein gene in the vector pGem9Zf(+) (Promega Corp 7113 Benhart Dr, Raleigh, NC). Vector and insert DNA can be ligated at 15 °C overnight, essentially as described (Maniatis). The ligated DNA may then be used to transform E. coli XL 1 -Blue (Epicurian Coli XL-1 ; Stratagene). Bacterial transformants can be screened by restriction enzyme digestion of plasmid DNA and limited nucleotide sequence analysis using the dideoxy chain termination method DNA Sequencing Kit; U. S. Biochemical). The resulting plasmid construct would comprise a chimeric gene encoding, in the 5' to 3' direction, the maize 27 kD zein promoter, a cDNA fragment encoding a plant GST enzyme, and the 10 kD zein 3' region. The chimeric gene described above can then be introduced into corn cells by the following procedure. Immature corn embryos can be dissected from developing caryopses derived from crosses of the inbred corn lines H99 and LH132 (Indiana Agric. Exp. Station, Indiana, USA). The embryos are isolated 10 to 11 days after pollination when they are 1.0 to 1.5 mm long. The embryos are then placed with the axis-side facing down and in contact with agarose-solidified N6 medium (Chu et al., (1975) Set. Sin. Peking 18:659-668). The embryos are kept in the dark at 27 °C. Friable embryogenic callus consisting of undifferentiated masses of cells with somatic proembryoids and embryoids borne on suspensor structures proliferates from the scutellum of these immature embryos. The embryogenic callus isolated from the primary explant can be cultured on N6 medium and sub-cultured on this medium every 2 to 3 weeks. The plasmid, p35S/Ac (obtained from Dr. Peter Eckes, Hoechst Ag, v Frankfurt, Germany) may be used in transformation experiments in order to provide for a selectable marker. This plasmid contains the Pat gene (see European Patent Publication 0 242 236) which encodes phosphinothricin acetyl transferase (PAT). The enzyme PAT confers resistance to herbicidal glutamine synthetase inhibitors such as phosphinothricin. The pat gene in p35S/Ac is under the control of the 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 313:810-812) and the 3M region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens. The particle bombardment method (Klein et al., (1987) Nature 327:70-73) may be used to transfer genes to the callus culture cells. According to this method, gold particles ((1 μm in diameter) are coated with DNA using the following technique. Ten ug of plasmid DNAs are added to 50 uL of a suspension of gold particles (60 mg per mL). Calcium chloride (50 μL of a 2.5 M solution) and spermidine free base (20 μL of a 1.0 M solution) are added to the particles. The suspension is vortexed during the addition of these solutions. After 10 minutes, the tubes are briefly centrifuged (5 sec at 15,000 rpm) and the supernatant removed. The particles are resuspended in 200 μL of absolute ethanol, centrifuged again and the supernatant removed. The ethanol rinse is performed again and the particles resuspended in a final volume of 30 uL of ethanol. An aliquot (5 μL) of the DNA-coated gold particles can be placed in the center of a flying disc (Bio-Rad Labs, 861 Ridgeview Dr, Medina, OH). The particles are then accelerated into the corn tissue with a PDS-1000/He (Bio-Rad Labs, 861 Ridgeview Dr, Medina, OH), using a helium pressure of 1000 psi, a gap distance of 0.5 cm and a flying distance of 1.0 cm. For bombardment, the embryogenic tissue is placed on filter paper over agarose- solidified N6 medium. The tissue is arranged as a thin lawn and covered a circular area of about 5 cm in diameter. The petri dish containing the tissue can be placed in the chamber of the PDS-1000/He approximately 8 cm from the stopping screen. The air in the chamber is then evacuated to a vacuum of 28 inches of Hg. The macrocarrier is accelerated with a helium shock wave using a rupture membrane that bursts when the He pressure in the shock tube reaches 1000 psi. Seven days after bombardment the tissue can be transferred to N6 medium that contains gluphosinate (2 mg per liter) and lacks casein or proline. The tissue continues to grow slowly on this medium. After an additional 2 weeks the tissue can be transferred to fresh N6 medium containing gluphosinate. After 6 weeks, areas of about 1 cm in diameter of actively growing callus can be identified on some of the plates containing the glufosinate-supplemented medium. These calli may continue to grow when sub-cultured on the selective medium. Plants can be regenerated from the transgenic callus by first transferring clusters of tissue to N6 medium supplemented with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be transferred to regeneration medium (Fromm et al., (1990) Bio/Technology 8:833-839). EXAMPLE 4 Expression of Chimeric Genes in Tobacco Cells (Dicotyledon) Cloning sites (Xbal or Smal) can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the digested vector pBI121 (Clonetech Inc., 6500 Donlon Rd, Somis, CA) or other appropriate transformation vector. Amplification could be performed as described above and the amplified DNA would then be digested with restriction enzymes Xbal and Smal and fractionated on a 0.7% low melting point agarose gel in 40 mM Tris- acetate, pH 8.5, 1 mM EDTA. The appropriate band can be excised from the gel, melted at 68 °C and combined with a 13 kb Xbal-Smal fragment of the plasmid pBI121 and handled as in Example 3. The resulting plasmid construct would comprise a chimeric gene encoding, in the 5' to 3' direction, right border region, the nos promoter linked to the NPT II gene and a nos terminator region followed by a cauliflower mosaic virus 35S promoter linked to a cDNA fragment encoding a plant GST enzyme and the nos terminator 3' region flanked by the left border region. The resulting plasmid could be mobilized into the Agrobacterium strain LBA4404/pAL4404 (Hoekema et al. Nature 303:179-180, (1983) using tri- parental matings (Ruvkin and Ausubel, Nature 289:85-88, (1981)). The resulting Agrobacterium strains could be then cocultivated with protoplasts (van den Elzen et al. Plant Mol. Biol, 5: 149-154 (1985)) or leaf disks (Horsch et al. Science 227:1229-1231, (1985)) of Nicotiana tabacum cv Wisconsin 38 and kanamycin- resistant transformants would be selected. Kanamycin-resistant transformed tobacco plants would be regenerated. EXAMPLE 5 Expression Of Chimeric Genes In Microbial Cells And Purification Of Gene Product Example 5 illustrates the expression of isolated full length genes encoding either class I, II or III GST proteins in E. coli. All clones listed in Table 2 were selected on the basis of homology to known GSTs using the BLAST algorithm as described in Example 2. Plasmid DNA was purified using QIAFilter cartridges (Qiagen. Inc., 9600 De Soto Ave, Chatsworth, CA) according to the manufacturer's instructions. Sequence was generated on an ABI Automatic sequencer using dye terminator technology (U.S. 5366860; EP 272007) using a combination of vector and insert-specific primers. Sequence editing was performed in either DNAStar (DNA, Star Inc.) or the Wisconsin GCG program (Wisconsin Package Version 9.0, Genetics Computer Group (GCG), Madison, WI). All sequences represent coverage at least two times in both directions. cDNA from the clones bmsl.pk0023.g8, csl.pk0010.c5, cebl.pk0017.a5, m.l5.5.d06.sk20, ceb5.pk0049.al 1, ceb5.pk0051.f8, and csl.pk0059.e2, encoding the instant maize GST enzymes were inserted into the ligation independent cloning (LIC) pET30 vector (Novagen, Inc., 597 Science Dr, Madison, WI) under the control of the T7 promoter, according to the manufacturer's instructions (see Novagen publications "LIC Vector Kits", publication number TB163 and U.S. 4952496). The vector was then used to transform BL21(DE3) competent E. coli hosts. Primers with a specific 3' extension designed for ligation independent cloning were designed to amplify the GST gene (Maniatis). Amplification products were gel-purified and annealed into the LIC vector after treatment with T4 DNA polymerase (Novagen). Insert-containing vectors were then used to transform NovaBlue competent E. coli cells and transformants were screened for the presence of viable inserts. Clones in the correct orientation with respect to the T7 promoter were transformed into BL21(DE3) competent cells (Novagen) and selected on LB agar plates containing 50 μg/mL kanamycin. Colonies arising from this transformation were grown overnight at 37 °C in Lauria Broth to OD 600 = 0.6 and induced with 1 mM IPTG and allowed to grow for an additional two hours. The culture was harvested, resuspended in binding buffer, lysed with a French press and cleared by centrifugation. Expressed protein was purified using the HIS binding kit (Novagen) according to the manufacturer's instructions. Purified protein was examined on 15-20% SDS Phast Gels (Bio-Rad Laboratories, 861 Ridgeview Dr, Medina, OH) and quantitated spectrophotometrically using BSA as a standard. Protein data is tabulated below in Table 3. TABLE 3 Protein Expression Data CLONE OD. 280 bmsl.pk0023.g8 0.57 csl.pk0010.c5 0.53 cebl.pk0017.a5 0.50 m.l5.5.d06.sk20 0.39 ceb5.pk0049.al 1 2.06 ceb5.ρk0051.f8 1.30 csl.pk0059.e2 1.45 EXAMPLE 6 Screening Of Expressed GST Enzymes For Substrate Metabolism The GST enzymes, expressed and purified as described in Example 5 were screened for their ability to metabolize a variety of substrates. Substrates tested included the three herbicide electrophilic substrates chlorimuron ethyl, alachlor, and Atrazine, and four model electrophilic substrates, l-chloro-2, 4-dinitro- benzene (CDNB), ethacrynic acid, t-stilbene oxide, and l,2-epoxy-3-(p-nitro- phenoxy) propane. The enzymes were purified as described in Example 5 and used in the following assay. For each enzyme, the conjugation reaction with each electrophilic substrate was performed by incubating 0.3 to 30 μg enzyme in 0.1 M MOPS (pH 7.0) containing 0.4 mM of the electrophilic substrate. The reaction was inititated by the addition of glutathione to a final concentration of 4 mM. After 5 to 30 min, the reaction was terminated by the addition of 45 μL acetonitrile, microfuged for 10 min to remove precipitated protein, and then the supernatent was removed and added to 65 μl of water. This sample was chromatographed on a Zorbax C8 reverse phase HPLC column (3 μm particle size, 6.2 mm x 8 cm) using a combination of linear gradients (flow = 1.5 mL/min) of 1% H3PO4 in water (solvent A) and 1% H3PO4 in acetonitrile. The gradient started with 5% solvent B, progressing from 5% to 75% solvent B between 1 and 10 min, and from 75% to 95%o solvent B between 10 and 12 min. Control reactions without enzyme were performed to correct for uncatalyzed reaction. Quantitation of metabolites were based on an assumption that the extinction coefficient of the conjugate was identical to that of the electrophilic substrate. Table 4 shows the activity of each enzyme measured in nmol'mhr^mg -1 with the seven different substrates. Activities are related to the activities of the known and previously isolated and purified GST enzymes, BZ-II (Marrs et al., Nature 375:397-400 (1995)), pIN2-l (Hershey et al., Plant Molecular Biology 17:679-690, (1991)), GST-I, GST-III, and GST-IV, collectively described in Shah et al., Plant Mol Biol 6, 203-211(1986); Jepson et al., Plant Mol Biol 26:1855-1866, (1994); Moore et al., Nucleic Acids Res 14:7227-7235 (1986); and Holt et al., Planta 196:295-302, (1995). TABLE 4 l,2-epoxy-3- Chlor- (p-nitro- GST Imuron- Ethacrynic t-Stilbene phenoxy) GST Name Class Ethyl Alachlor Atrazine CDNB Acid Oxide propane csl.pk0059.e2 III 0.1 8 0.02 1348 20 1.25 43 ceb5.pk0049.al l III 0.4 18 0.01 3939 102 0.01 30 ceb5.pk0051.f8 III 1.9 27 0.08 2136 117 0.02 14 BZ-II III 0.2 0 0.00 15 23 0.05 0 cebl.pk0017.a5 I 0.1 0 0.00 15 5 0.00 0 csl.pk0010.c5 I 0.1 0 0.00 30 9 0.00 0 bmsl.pk0023.g8 I 0.2 0 0.00 15 13 0.00 0 GST-IV I 0.3 1 0.00 15 13 0.00 0 GST-I I 0.4 77 0.60 46485 32 0.98 92 GST-III I 0.3 3 0.05 1803 1 0.31 28 m.l5.5.d06.sk20 II 0.1 0 0.00 45 17 0.00 1 pIN2-l IV 0 0 — 15 — — — INDICATIONS RELATING TO A DEPOSITED MICROORGANISM (PCT Rule l36/.r) A. The indications made below relate to the microorganism referred to in the description on page 10 . line 21 B. IDENTIFICATION OF DEPOSIT Further deposits are identified on an additional sheet Name of depositary institution AMERICAN TYPE CULTURE COLLECTION Address of depositary institution (including postal code and country) 10801 University Blvd. Manassas, Virginia 20110-2209 USA Date of deposit Accession Number 21 August 1997 98511 C. ADDITIONAL INDICATIONS (leave blank if not applicable) This information is continued on an additional sheet Q In respect of those designations in which a European patent is sought, a sample of the deposited microorganism will be made available until the publication of the mention of the grant of the European patent or until the date on which the application has been refused or withdrawn or. is deemed to be withdrawn, only by the issue of such a sample to an expert nominated by the person requesting the sample. (Rule 28(4) EPC) D. DESIGNATED STATES FOR WHICH INDICATIONS ARE MADE (if the indications are not for all designated States) E. SEPARATE FURNISHING OF INDICATIONS (leave blank if not applicable) The indications listed below will be submitted to the International Bureau later (specify the general nature of ' the indications e.g.. "Accession Number of Deposit") For receiving Office use only For International Bureau use only j I This sheet was received with the international application I I This sheet was received by the International Bureau on: Authorized officer Authorized officer Form PCT/RO/134 (July 1992)

Claims: What is claimed is: 1. An isolated nucleic acid fragment encoding a maize GST enzyme selected from the group consisting of: (a) an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO:20, SEQ ID NO:22, and SEQ ID NO:24; (b) an isolated nucleic acid fragment that is substantially similar to an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO:20, SEQ ID NO:22, and SEQ ID NO:24; and (c) an isolated nucleic acid fragment that is complementary to (a) or (b). 2. The isolated nucleic acid fragment of Claim 1 selected from the group consisting of SEQ ID NO: 1 , SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:l 1, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO:19, SEQ ID NO:21, and SEQ ID NO:23. 3. A polypeptide encoded by the isolated nucleic acid fragment of Claim 1. 4. The polypeptide of Claim 3 selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO:20, SEQ ID NO:22, and SEQ ID NO:24. 5. A chimeric gene comprising the isolated nucleic acid fragment of Claim 1 operably linked to suitable regulatory sequences. 6. A transformed host cell comprising a host cell and the chimeric gene of Claim 5. 7. The transformed host cell of Claim 6 wherein the host cell is a plant cell. 8. The transformed host cell of Claim 6 wherein the host cell is E. coli. 9. A method of altering the level of expression of a maize GST enzyme in a host cell comprising: (a) transforming a host cell with the chimeric gene of Claim 5 and; (b) growing the transformed host cell produced in step (a) under conditions that are suitable for expression of the chimeric gene resultin in production of altered levels of a maize GST enzyme in the transformed host cell relative to expression levels of an untransformed host cell. 10. A method of obtaining a nucleic acid fragment encoding all or a substantial portion of the amino acid sequence encoding a maize GST enzyme comprising: (a) probing a cDNA or genomic library with the nucleic acid fragment of Claim 1 ; (b) identifying a DNA clone that hybridizes with the nucleic acid fragment of Claim 1 ; and (c) sequencing the cDNA or genomic fragment that comprises the clone identified in step (b), wherein the sequenced cDNA or genomic fragment encodes all or substantially all of the amino acid sequence encoding a maize GST enzyme 11. A method of obtaining a nucleic acid fragment encoding all or a substantial portion of the amino acid sequence encoding a maize GST enzyme comprising: (a) synthesizing an oligonucleotide primer corresponding to a portion of the sequence selected from the group consisting of SEQ ID NO:l, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO:17, SEQ ID NO:19, SEQ ID NO:21, and SEQ ID NO:23; (b) amplifying a cDNA insert present in a cloning vector using the oligonucleotide primer of step (a) and a primer representing sequences of the cloning vector, wherein the amplified cDNA insert encodes a portion of an amino acid sequence encoding a maize GST enzyme. 12. The product of the method of Claim 10 or 11. 13. A method for identifying a chemical compound that inhibits the activity of a maize GST enzyme encoded by the nucleic acid fragment of Claim 1 , the method comprising the steps of: (a) transforming a host cell with a chimeric gene comprising the nucleic acid fragment of Claim 1 encoding a maize GST enzyme, the chimeric gene operably linked to at least one suitable regulatory sequence; (b) growing the transformed host cell of step (a) under conditions suitable for expression of the chimeric gene resulting in production of the GST enzyme; (c) optionally purifying the GST enzyme expressed by the transformed host cell; (d) contacting the GST enzyme with a chemical compound of interest; and (e) identifying the chemical compound of interest that reduces the activity of the maize GST enzyme relative to the activity of the maize GST enzyme in the absence of the chemical compound of interest. 14. The method of Claim 13 wherein step (d) is carried out in the presence of at least one electrophilic substrate and at least one thiol donor. 15. The method of Claim 13 wherein said nucleic acid fragment is selected from the group consisting of SEQ ID NO: 1 , SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO.9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO:17, SEQ ID NO:19, SEQ ID NO:21, and SEQ ID NO:23, and wherein the maize GST enzyme is selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO:20, SEQ ID NO:22, and SEQ ID NO:24. 16. A method for identifying a chemical compound that inhibits the activity of a maize GST enzyme encoded by the nucleic acid fragment of Claim 1 , the method comprising the steps of: (a) transforming a host cell with a chimeric gene comprising a nucleic acid fragment of Claim 1 encoding a maize GST enzyme, the chimeric gene operably linked to at least one regulatory sequence; (b) growing the transformed host cell of step (a) under conditions suitable for expression of the chimeric gene resulting in production of the GST enzyme; (c) contacting the transformed host cell of step (b) with an inhibitor candidate; and (d) comparing the phenotype of the transformed host cell contacted with an inhibitor candidate with the phenotype of the transformed host cell that was not contacted with an inhibitor candidate to identify the chemical compound that inhibits the activity of the soybean GST enzyme. 17. The method of Claim 16 wherein the nucleic acid fragment is selected from the group consisting of SEQ ID NO:l, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:9, SEQ ID NO.l l, SEQ ID NO.13, SEQ ID NO:15, SEQ ID NO.17, SEQ ID NO:19, SEQ ID NO:21, and SEQ ID NO:23, and wherein the maize GST enzyme is selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO:20, SEQ ID NO:22, and SEQ ID NO:24. 18. A method for identifying a substrate for a GST enzyme, the GST enzyme encoded by the isolated nucleic acid fragment of Claim 1 , the method comprising the steps of: (a) transforming a host cell with a chimeric gene comprising an isolated nucleic acid fragment of Claim 1 encoding a maize GST enzyme, the chimeric gene operably linked to at least one suitable regulatory sequence; (b) growing the transformed host cell of step (a) under conditions suitable for expression of the chimeric gene resulting in production of the soybean GST enzyme; (c) optionally purifying the GST enzyme expressed by the transformed host cell; (d) contacting the soybean GST enzyme with a substrate candidate; and (e) comparing the activity of soybean GST enzyme that has been contacted with the substrate candidate with soybean GST enzyme that has not been contacted with the substrate candidate, selecting substrate candidates that increase the activity of the soybean GST enzyme relative to the activity of the soybean GST enzyme in the absence of a substrate candidate. 19. The method of Claim 18 wherein step (d) is carried out in the presence of at least one thiol donor. 20. The method of Claim 18 wherein the nucleic acid fragment is selected from the group consisting of SEQ ID NO:l, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO.9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO:21, and SEQ ID NO:23, and wherein the maize GST enzyme is selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:10, SEQ ID NO.12, SEQ ID NO:14, SEQ ID NO:16, SEQ ID NO: 18, SEQ ID NO:20, SEQ ID NO:22, and SEQ ID NO:24. 21. A method for identifying a substrate for a maize GST enzyme, the method comprising the steps of: (a) transforming a host cell with a chimeric gene comprising a nucleic acid fragment of Claim 1 , the chimeric gene operably linked to at least one suitable regulatory sequence; (b) growing the transformed host cell of step (a) under conditions suitable for expression of the chimeric gene resulting in production of the maize GST enzyme; (c) contacting the transformed host cell of step (b) with a maize GST substrate candidate; and (d) comparing the phenotype of the transformed host cell contacted with the substrate candidate with the phenotype of the transformed host cell that was not contacted with the substrate candidate to identify a soybean GST enzyme substrate. 22. The method of Claim 21 wherein the nucleic acid fragment is selected from the group consisting of SEQ ID NO:l, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:9, SEQ ID NO.l l, SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:17, SEQ ID NO: 19, SEQ ID NO.21, and SEQ ID NO:23, and wherein the maize GST enzyme is selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:10, SEQ ID NO.12, SEQ ID NO.14, SEQ ID NO:16, SEQ ID NO: 18, SEQ ID NO:20, SEQ ID NO:22, and SEQ ID NO:24. 23. An isolated nucleic acid fragment encoding a GST enzyme selected from the group consisting of: (a) an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence selected from the group consisting of SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:38, SEQ ID NO:40, SEQ ID NO:42, SEQ ID NO:44, SEQ ID NO:46, SEQ ID NO:48, SEQ ID NO:50, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72 and SEQ ID NO:74; (b) an isolated nucleic acid fragment that is substantially similar to an isolated nucleic acid fragment encoding all or a substantial portion of the amino acid sequence selected from the group consisting of SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:38, SEQ ID NO:40, SEQ ID NO:42, SEQ ID NO:44, SEQ ID NO:46, SEQ ID NO:48, SEQ ID NO:50, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72 and SEQ ID NO:74; and (c) an isolated nucleic acid fragment that is complementary to (a) or (b). 24. The isolated nucleic acid fragment of Claim 23 selected from the group consisting of SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:29, SEQ ID NO:31, SEQ ID NO:33, SEQ ID NO:35, SEQ ID NO:37, SEQ ID NO:39, SEQ ID NO:41, SEQ ID NO:43, SEQ ID NO:45, SEQ ID NO:47, SEQ ID NO:49, SEQ ID NO:51, SEQ ID NO:53, SEQ ID NO:55, SEQ ID NO:57, SEQ ID NO:59, SEQ ID NO:61, SEQ ID NO:63, SEQ ID NO:65, SEQ ID NO:67, SEQ ID NO69, SEQ ID NO:71 and SEQ ID NO:73. 25. A polypeptide encoded by the isolated nucleic acid fragment of Claim 23. 26. The polypeptide of Claim 25 selected from the group consisting of SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:38, SEQ ID NO:40, SEQ ID NO:42, SEQ ID NO:44, SEQ ID NO:46, SEQ ID NO:48, SEQ ID NO:50, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72 and SEQ ID NO:74; 27. A chimeric gene comprising the isolated nucleic acid fragment of Claim 23 operably linked to suitable regulatory sequences. 28. A transformed host cell comprising a host cell and the chimeric gene of Claim 27. 29. The transformed host cell of Claim 28 wherein the host cell is a plant cell. 30. The transformed host cell of Claim 28 wherein the host cell is E. coli. 31. A method of altering the level of expression of a GST enzyme in a host cell comprising: (a) transforming a host cell with the chimeric gene of Claim 27 and; (b) growing the transformed host cell produced in step (a) under conditions that are suitable for expression of the chimeric gene resulting in production of altered levels of a GST enzyme in the transformed host cell relative to expression levels of an untransformed host cell. 32. A method of obtaining a nucleic acid fragment encoding all or a substantial portion of the amino acid sequence encoding a GST enzyme comprising: (a) probing a cDNA or genomic library with the nucleic acid fragment of Claim 23; (b) identifying a DNA clone that hybridizes with the nucleic acid fragment of Claim 23; and (c) sequencing the cDNA or genomic fragment that comprises the clone identified in step (b), wherein the sequenced cDNA or genomic fragment encodes all or substantially all of the amino acid sequence encoding a GST enzyme. 33. A method of obtaining a nucleic acid fragment encoding all or a substantial portion of the amino acid sequence encoding a GST enzyme comprising: (a) synthesizing at least one oligonucleotide primer corresponding to a portion of the sequence selected from the group consisting of SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:29, SEQ ID NO:31, SEQ ID NO:33, SEQ ID NO:35, SEQ ID NO:37, SEQ ID NO:39, SEQ ID NO.41, SEQ ID NO:43, SEQ ID NO:45, SEQ ID NO:47, SEQ ID NO:49, SEQ ID NO:51, SEQ ID NO:53, SEQ ID NO:55, SEQ ID NO:57, SEQ ID NO:59, SEQ ID NO.61, SEQ ID NO:63, SEQ ID NO:65, SEQ ID NO:67, SEQ ID NO69, SEQ ID NO:71 and SEQ ID NO:73; and (b) amplifying a cDNA insert present in a cloning vector using the oligonucleotide primer of step (a), wherein the amplified cDNA insert encodes a portion of an amino acid sequence encoding a GST enzyme. 34. The product of the method of Claims 32 or 33. 35. A method for identifying a chemical compound that inhibits the activity of a GST enzyme encoded by the nucleic acid fragment of Claim 23, the method comprising the steps of: (a) transforming a host cell with a chimeric gene comprising the nucleic acid fragment of Claim 23 encoding a GST enzyme, the chimeric gene operably linked to at least one suitable regulatory sequence; (b) growing the transformed host cell of step (a) under conditions suitable for expression of the chimeric gene resulting in production of the GST enzyme; (c) optionally purifying the GST enzyme expressed by the transformed host cell; (d) contacting the GST enzyme with a chemical compound of interest; and (e) identifying the chemical compound of interest that reduces the activity of the GST enzyme relative to the activity of the GST enzyme in the absence of the chemical compound of interest. 36. The method of Claim 35 wherein step (d) is carried out in the presence of at least one electrophilic substrate and at least one thiol donor. 37. The method of Claim 35 wherein the nucleic acid fragment is selected from the group consisting of SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:29, SEQ ID NO:31, SEQ ID NO:33, SEQ ID NO:35, SEQ ID NO:37, SEQ ID NO:39, SEQ ID NO.41, SEQ ID NO:43, SEQ ID NO:45, SEQ ID NO:47, SEQ ID NO:49, SEQ ID NO:51, SEQ ID NO:53, SEQ ID NO:55, SEQ ID NO:57, SEQ ID NO:59, SEQ ID NO:61, SEQ ID NO:63, SEQ ID NO:65, SEQ ID NO:67, SEQ ID NO69, SEQ ID NO:71 and SEQ ID NO:73, and wherein the GST enzyme is selected from the group consisting of SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:38, SEQ ID NO:40, SEQ ID NO:42, SEQ ID NO:44, SEQ ID NO:46, SEQ ID NO:48, SEQ ID NO:50, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72 and SEQ ID NO:74. 38. A method for identifying a chemical compound that inhibits the activity of a GST enzyme encoded by the nucleic acid fragment of Claim 23, the method comprising the steps of: (a) transforming a host cell with a chimeric gene comprising a nucleic acid fragment of Claim 23 encoding a GST enzyme, the chimeric gene operably linked to at least one regulatory sequence; (b) growing the transformed host cell of step (a) under conditions suitable for expression of the chimeric gene resulting in production of the GST enzyme; (c) contacting the transformed host cell of step (b) with an inhibitor candidate; and (d) comparing the phenotype of the transformed host cell contacted with an inhibitor candidate with the phenotype of the transformed host cell that was not contacted with an inhibitor candidate to identify the chemical compound that inhibits the activity of the GST enzyme. 39. The method of Claim 38 wherein the nucleic acid fragment of Claim 23 is selected from the group consisting of SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:29, SEQ ID NO.31, SEQ ID NO:33, SEQ ID NO:35, SEQ ID NO:37, SEQ ID NO:39, SEQ ID NO.41, SEQ ID NO:43, SEQ ID NO:45, SEQ ID NO:47, SEQ ID NO:49, SEQ ID NO.51, SEQ ID NO:53, SEQ ID NO:55, SEQ ID NO:57, SEQ ID NO:59, SEQ ID NO.61, SEQ ID NO:63, SEQ ID NO:65, SEQ ID NO:67, SEQ ID NO69, SEQ ID NO:71 and SEQ ID NO:73, and wherein the GST enzyme is selected from the group consisting of SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:38, SEQ ID NO:40, SEQ ID NO:42, SEQ ID NO:44, SEQ ID NO:46, SEQ ID NO:48, SEQ ID NO:50, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72 and SEQ ID NO:74. 40. A method for identifying a substrate for a GST enzyme, the GST enzyme encoded by the isolated nucleic acid fragment of Claim 23, the method comprising the steps of: (a) transforming a host cell with a chimeric gene comprising an isolated nucleic acid fragment of Claim 23 encoding a GST enzyme, the chimeric gene operably linked to at least one suitable regulatory sequence; (b) growing the transformed host cell of step (a) under conditions suitable for expression of the chimeric gene resulting in production of the GST enzyme; (c) optionally purifying the GST enzyme expressed by the transformed host cell; (d) contacting the GST enzyme with a substrate candidate; and (e) comparing the activity of GST enzyme that has been contacted with the substrate candidate with GST enzyme that has not been contacted with the substrate candidate, selecting substrate candidates that increase the activity of the GST enzyme relative to the activity of the GST enzyme in the absence of a substrate candidate. 41. The method of Claim 40 wherein step (d) is carried out in the presence of at least one thiol donor. 42. The method of Claim 40 wherein the nucleic acid fragment of Claim 23 is selected from the group consisting of SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO.29, SEQ ID NO:31, SEQ ID NO:33, SEQ ID NO:35, SEQ ID NO:37, SEQ ID NO:39, SEQ ID NO.41, SEQ ID NO:43, SEQ ID NO:45, SEQ ID NO:47, SEQ ID NO:49, SEQ ID NO:51, SEQ ID NO:53, SEQ ID NO:55, SEQ ID NO:57, SEQ ID NO:59, SEQ ID NO.61, SEQ ID NO:63, SEQ ID NO:65, SEQ ID NO:67, SEQ ID NO69, SEQ ID NO:71 and SEQ ID NO:73, and wherein the GST enzyme is selected from the group consisting of SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:38, SEQ ID NO:40, SEQ ID NO:42, SEQ ID NO:44, SEQ ID NO:46, SEQ ID NO:48, SEQ ID NO:50, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72 and SEQ ID NO:74. 43. A method for identifying a substrate for a GST enzyme, the method comprising the steps of: (a) transforming a host cell with a chimeric gene comprising a nucleic acid fragment of Claim 23, the chimeric gene operably linked to at least one suitable regulatory sequence; (b) growing the transformed host cell of step (a) under conditions suitable for expression of the chimeric gene resulting in production of the GST enzyme; (c) contacting the transformed host cell of step (b) with a GST substrate candidate; and (d) comparing the phenotype of the transformed host cell contacted with the substrate candidate with the phenotype of the transformed host cell that was not contacted with the substrate candidate to identify a GST enzyme substrate. 44. The method of Claim 43 wherein the nucleic acid fragment of Claim 23 is selected from the group consisting of SEQ ID NO:25, SEQ ID NO:27, SEQ ID NO:29, SEQ ID NO:31, SEQ ID NO:33, SEQ ID NO:35, SEQ ID NO:37, SEQ ID NO:39, SEQ ID NO:41, SEQ ID NO:43, SEQ ID NO:45, SEQ ID NO:47, SEQ ID NO:49, SEQ ID NO.51, SEQ ID NO:53, SEQ ID NO:55, SEQ ID NO:57, SEQ ID NO:59, SEQ ID NO:61, SEQ ID NO:63, SEQ ID NO:65, SEQ ID NO:67, SEQ ID NO69, SEQ ID NO:71 and SEQ ID NO:73, and wherein the GST enzyme is selected from the group consisting of SEQ ID NO:26, SEQ ID NO.28, SEQ ID NO:30, SEQ ID NO:32, SEQ ID NO:34, SEQ ID NO:36, SEQ ID NO:38, SEQ ID NO:40, SEQ ID NO:42, SEQ ID NO:44, SEQ ID NO:46, SEQ ID NO:48, SEQ ID NO:50, SEQ ID NO:52, SEQ ID NO:54, SEQ ID NO:56, SEQ ID NO:58, SEQ ID NO:60, SEQ ID NO:62, SEQ ID NO:64, SEQ ID NO:66, SEQ ID NO:68, SEQ ID NO:70, SEQ ID NO:72 and SEQ ID NO:74.

Inventors: MCGONIGLE BRIAN, O'KEEFE DANIEL P, MCGONIGLE, BRIAN, O'KEEFE, DANIEL, P.
Applicants: DU PONT, E.I. DU PONT DE NEMOURS AND COMPANY
Application year: 2000
Main classification: C12N15
IPC codes: C12N9, C12N15